Chr	Start	End	Ref	Alt	oncoKB_annotation
chr9	133738363	133738363	G	A	Biomarker=E255K;Evidence_level=2A|2A;Drug=Bosutinib/Dasatinib|Bosutinib/Dasatinib;Tumor_type=Chronic_Myelogenous_Leukemia|B_Lymphoblastic_Leukemia/Lymphoma
chr9	133738364	133738364	A	T	Biomarker=E255V;Evidence_level=2A|2A;Drug=Bosutinib/Dasatinib|Bosutinib/Dasatinib;Tumor_type=Chronic_Myelogenous_Leukemia|B_Lymphoblastic_Leukemia/Lymphoma
chr9	133748289	133748289	T	G	Biomarker=F317C;Evidence_level=2A|2A;Drug=Bosutinib/Nilotinib|Bosutinib/Nilotinib;Tumor_type=B_Lymphoblastic_Leukemia/Lymphoma|Chronic_Myelogenous_Leukemia
chr9	133748288	133748288	T	A	Biomarker=F317I;Evidence_level=2A|2A;Drug=Bosutinib/Nilotinib|Bosutinib/Nilotinib;Tumor_type=B_Lymphoblastic_Leukemia/Lymphoma|Chronic_Myelogenous_Leukemia
chr9	133748288	133748288	T	C	Biomarker=F317L;Evidence_level=2A|2A;Drug=Bosutinib/Nilotinib|Bosutinib/Nilotinib;Tumor_type=B_Lymphoblastic_Leukemia/Lymphoma|Chronic_Myelogenous_Leukemia
chr9	133748288	133748288	T	G	Biomarker=F317V;Evidence_level=2A|2A;Drug=Bosutinib/Nilotinib|Bosutinib/Nilotinib;Tumor_type=Chronic_Myelogenous_Leukemia|B_Lymphoblastic_Leukemia/Lymphoma
chr9	133748415	133748415	T	G	Biomarker=F359C;Evidence_level=2A|2A;Drug=Bosutinib/Dasatinib|Bosutinib/Dasatinib;Tumor_type=Chronic_Myelogenous_Leukemia|B_Lymphoblastic_Leukemia/Lymphoma
chr9	133748414	133748414	T	A	Biomarker=F359I;Evidence_level=2A|2A;Drug=Bosutinib/Dasatinib|Bosutinib/Dasatinib;Tumor_type=B_Lymphoblastic_Leukemia/Lymphoma|Chronic_Myelogenous_Leukemia
chr9	133748414	133748414	T	G	Biomarker=F359V;Evidence_level=2A|2A;Drug=Bosutinib/Dasatinib|Bosutinib/Dasatinib;Tumor_type=B_Lymphoblastic_Leukemia/Lymphoma|Chronic_Myelogenous_Leukemia
chr9	133748282	133748282	A	G	Biomarker=T315A;Evidence_level=2A|2A;Drug=Bosutinib/Nilotinib|Bosutinib/Nilotinib;Tumor_type=B_Lymphoblastic_Leukemia/Lymphoma|Chronic_Myelogenous_Leukemia
chr9	133748283	133748283	C	T	Biomarker=T315I;Evidence_level=1|R1|1|R1;Drug=Ponatinib|Bosutinib/Dasatinib/Imatinib/Nilotinib|Ponatinib|Bosutinib/Dasatinib/Imatinib/Nilotinib;Tumor_type=Chronic_Myelogenous_Leukemia|B_Lymphoblastic_Leukemia/Lymphoma|B_Lymphoblastic_Leukemia/Lymphoma|Chronic_Myelogenous_Leukemia
chr9	133747588	133747588	G	C	Biomarker=V299L;Evidence_level=2A|2A;Drug=Nilotinib|Nilotinib;Tumor_type=Chronic_Myelogenous_Leukemia|B_Lymphoblastic_Leukemia/Lymphoma
chr9	133738357	133738357	T	C	Biomarker=Y253H;Evidence_level=2A|2A;Drug=Bosutinib/Dasatinib|Bosutinib/Dasatinib;Tumor_type=Chronic_Myelogenous_Leukemia|B_Lymphoblastic_Leukemia/Lymphoma
chr14	105246551	105246551	C	T	Biomarker=E17K;Evidence_level=3A|3A|3A;Drug=AZD5363|AZD5363|AZD5363;Tumor_type=Breast_Cancer|Ovarian_Cancer|Endometrial_Cancer
chr2	29445258	29445258	C	T	Biomarker=C1156Y;Evidence_level=R2|1;Drug=Crizotinib|Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer|Non_Small_Cell_Lung_Cancer
chr2	29443613	29443613	C	T	Biomarker=G1202R;Evidence_level=R2|1;Drug=Alectinib|Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer|Non_Small_Cell_Lung_Cancer
chr2	29432682	29432682	C	G	Biomarker=G1269A;Evidence_level=R2|1;Drug=Crizotinib|Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer|Non_Small_Cell_Lung_Cancer
chr2	29445213	29445213	A	T	Biomarker=I1171N;Evidence_level=R2|1;Drug=Alectinib|Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer|Non_Small_Cell_Lung_Cancer
chr2	29443631	29443631	G	T	Biomarker=L1196M;Evidence_level=R2|1;Drug=Crizotinib|Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer|Non_Small_Cell_Lung_Cancer
chr2	29445258	29445258	C	A	Biomarker=C1156F;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29446296	29446296	C	T	Biomarker=D1091N;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29443610	29443610	C	T	Biomarker=D1203N;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29443589	29443589	C	T	Biomarker=E1210K;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29419650	29419650	C	T	Biomarker=E1384K;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29443696	29443696	A	C	Biomarker=F1174C;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29443697	29443697	A	T	Biomarker=F1174I;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29443697	29443697	A	G	Biomarker=F1174L;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29443696	29443696	A	G	Biomarker=F1174S;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29443697	29443697	A	C	Biomarker=F1174V;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29436859	29436859	A	C	Biomarker=F1245C;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29436860	29436860	A	C	Biomarker=F1245V;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29445465	29445465	C	T	Biomarker=G1123D;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29445466	29445466	C	T	Biomarker=G1123S;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29445450	29445450	C	G	Biomarker=G1128A;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29445449	29445451	GGG	AGC	Biomarker=G1128S;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29443615	29443615	C	T	Biomarker=G1201E;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29432681	29432683	GGA	AGC	Biomarker=G1269S;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29451923	29451923	C	T	Biomarker=G881D;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29474094	29474094	T	C	Biomarker=H694R;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29445216	29445216	A	T	Biomarker=I1170N;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29445216	29445216	A	C	Biomarker=I1170S;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29445213	29445213	A	C	Biomarker=I1171S;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29445213	29445213	A	G	Biomarker=I1171T;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29446382	29446382	T	A	Biomarker=K1062M;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29445469	29445469	G	C	Biomarker=L1122V;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29445270	29445270	A	G	Biomarker=L1152P;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29445270	29445270	A	C	Biomarker=L1152R;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29443630	29443630	A	T	Biomarker=L1196Q;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29443625	29443625	G	A	Biomarker=L1198F;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29443624	29443624	A	G	Biomarker=L1198P;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29436875	29436875	A	C	Biomarker=L1240V;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29445228	29445228	A	C	Biomarker=M1166R;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29420497	29420497	C	G	Biomarker=M1328I;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29443685	29443685	T	G	Biomarker=N1178H;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29445418	29445418	G	A	Biomarker=P1139S;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29446376	29446376	T	C	Biomarker=Q1064R;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29443642	29443642	C	G	Biomarker=R1192P;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29432664	29432664	C	A	Biomarker=R1275L;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29432664	29432664	C	T	Biomarker=R1275Q;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29443600	29443600	G	C	Biomarker=S1206C;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29443600	29443600	G	A	Biomarker=S1206F;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29443600	29443601	TC	CG	Biomarker=S1206R;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29443600	29443600	G	T	Biomarker=S1206Y;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29445271	29445271	-	CGT	Biomarker=T1151dup;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29443679	29443679	C	G	Biomarker=V1180L;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29519781	29519781	A	G	Biomarker=V597A;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr2	29432655	29432655	T	G	Biomarker=Y1278S;Evidence_level=1;Drug=Brigatinib/Lorlatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chrX	47426806	47426806	T	C	Biomarker=F351L;Evidence_level=3A|3A;Drug=Cobimetinib/Sorafenib|Sorafenib;Tumor_type=Histiocytosis|Non_Small_Cell_Lung_Cancer
chrX	47426719	47426719	G	A	Biomarker=G322S;Evidence_level=3A|3A;Drug=Cobimetinib/Sorafenib|Sorafenib;Tumor_type=Histiocytosis|Non_Small_Cell_Lung_Cancer
chrX	47426130	47426130	A	T	Biomarker=N217I;Evidence_level=3A|3A;Drug=Cobimetinib/Sorafenib|Sorafenib;Tumor_type=Histiocytosis|Non_Small_Cell_Lung_Cancer
chrX	47426126	47426126	C	G	Biomarker=P216A;Evidence_level=3A|3A;Drug=Cobimetinib/Sorafenib|Sorafenib;Tumor_type=Histiocytosis|Non_Small_Cell_Lung_Cancer
chrX	47426794	47426799	CAGGCC	-	Biomarker=Q347_A348del;Evidence_level=3A|3A;Drug=Cobimetinib/Sorafenib|Sorafenib;Tumor_type=Histiocytosis|Non_Small_Cell_Lung_Cancer
chrX	47426120	47426120	T	G	Biomarker=S214A;Evidence_level=3A|3A;Drug=Cobimetinib/Sorafenib|Sorafenib;Tumor_type=Histiocytosis|Non_Small_Cell_Lung_Cancer
chrX	47426121	47426121	C	G	Biomarker=S214C;Evidence_level=3A|3A;Drug=Cobimetinib/Sorafenib|Sorafenib;Tumor_type=Histiocytosis|Non_Small_Cell_Lung_Cancer
chrX	47426121	47426121	C	T	Biomarker=S214F;Evidence_level=3A|3A;Drug=Cobimetinib/Sorafenib|Sorafenib;Tumor_type=Histiocytosis|Non_Small_Cell_Lung_Cancer
chrX	47426120	47426120	T	A	Biomarker=S214T;Evidence_level=3A|3A;Drug=Cobimetinib/Sorafenib|Sorafenib;Tumor_type=Histiocytosis|Non_Small_Cell_Lung_Cancer
chr11	108218030	108218030	A	C	Biomarker=D2870A;Evidence_level=4;Drug=Olaparib;Tumor_type=All_Solid_Tumors
chr11	108183151	108183151	G	T	Biomarker=E1978*;Evidence_level=4;Drug=Olaparib;Tumor_type=All_Solid_Tumors
chr11	108218046	108218046	T	G	Biomarker=N2875K;Evidence_level=4;Drug=Olaparib;Tumor_type=All_Solid_Tumors
chr11	108186638	108186638	G	A	Biomarker=R2032K;Evidence_level=4;Drug=Olaparib;Tumor_type=All_Solid_Tumors
chr11	108202615	108202623	AGAATTTCA	-	Biomarker=R2547_S2549del;Evidence_level=4;Drug=Olaparib;Tumor_type=All_Solid_Tumors
chr11	108203626	108203626	A	C	Biomarker=R2642S;Evidence_level=4;Drug=Olaparib;Tumor_type=All_Solid_Tumors
chr11	108216545	108216545	C	T	Biomarker=R2832C;Evidence_level=4;Drug=Olaparib;Tumor_type=All_Solid_Tumors
chr11	108236086	108236086	C	T	Biomarker=R3008C;Evidence_level=4;Drug=Olaparib;Tumor_type=All_Solid_Tumors
chr11	108202751	108202751	C	G	Biomarker=S2592C;Evidence_level=4;Drug=Olaparib;Tumor_type=All_Solid_Tumors
chr11	108172425	108172425	C	T	Biomarker=T1743I;Evidence_level=4;Drug=Olaparib;Tumor_type=All_Solid_Tumors
chr11	108199929	108199929	T	G	Biomarker=V2424G;Evidence_level=4;Drug=Olaparib;Tumor_type=All_Solid_Tumors
chr7	140481402	140481402	C	G	Biomarker=G469A;Evidence_level=4|3A;Drug=PLX8394|Cobimetinib;Tumor_type=All_Solid_Tumors|Histiocytosis
chr7	140481403	140481403	C	T	Biomarker=G469R;Evidence_level=4|3A;Drug=PLX8394|Cobimetinib;Tumor_type=All_Solid_Tumors|Histiocytosis
chr7	140481402	140481402	C	A	Biomarker=G469V;Evidence_level=4|3A;Drug=PLX8394|Cobimetinib;Tumor_type=All_Solid_Tumors|Histiocytosis
chr7	140501336	140501336	C	G	Biomarker=A246P;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453142	140453142	G	A	Biomarker=A598V;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140434515	140434515	G	A	Biomarker=A728V;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140501213	140501213	C	G	Biomarker=D287H;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453154	140453154	T	G	Biomarker=D594A;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453153	140453153	A	C	Biomarker=D594E;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453154	140453154	T	C	Biomarker=D594G;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453155	140453155	C	G	Biomarker=D594H;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453155	140453155	C	T	Biomarker=D594N;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453154	140453154	T	A	Biomarker=D594V;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453155	140453155	C	A	Biomarker=D594Y;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140501249	140501249	C	T	Biomarker=E275K;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453179	140453179	C	T	Biomarker=E586K;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140501333	140501333	A	G	Biomarker=F247L;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140481405	140481405	A	C	Biomarker=F468C;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453152	140453152	A	G	Biomarker=F595L;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140481417	140481417	C	T	Biomarker=G464E;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140481418	140481418	C	T	Biomarker=G464R;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140481417	140481417	C	A	Biomarker=G464V;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140481411	140481411	C	G	Biomarker=G466A;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140481411	140481411	C	T	Biomarker=G466E;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140481412	140481412	C	T	Biomarker=G466R;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140481411	140481411	C	A	Biomarker=G466V;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140481402	140481402	C	T	Biomarker=G469E;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140481402	140481403	GG	CT	Biomarker=G469L;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140481401	140481403	TCC	-	Biomarker=G469del;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453149	140453149	C	A	Biomarker=G596C;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453148	140453148	C	T	Biomarker=G596D;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453149	140453149	C	G	Biomarker=G596R;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453148	140453148	C	A	Biomarker=G596V;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140454006	140454006	G	T	Biomarker=H574Q;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140477861	140477861	T	C	Biomarker=K483E;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140477859	140477860	AA	TG	Biomarker=K483M;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140477813	140477813	T	C	Biomarker=K499E;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453134	140453134	T	C	Biomarker=K601E;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453132	140453132	T	G	Biomarker=K601N;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453134	140453134	T	G	Biomarker=K601Q;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453133	140453133	T	G	Biomarker=K601T;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453129	140453134	AGATTT	TGTGTT	Biomarker=K601_S602delinsNT;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140477853	140477853	C	A	Biomarker=L485F;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140477838	140477855	AGGTGCTGTCACATTCAA	-	Biomarker=L485_P490del;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140477839	140477853	GGTGCTGTCACATTC	-	Biomarker=L485_P490delinsF;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140477838	140477855	AGGTGCTGTCACATTCAA	ATA	Biomarker=L485_P490delinsY;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140477824	140477853	AACTGCTGAGGTGTAGGTGCTGTCACATTC	-	Biomarker=L485_Q494del;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140477794	140477794	A	T	Biomarker=L505H;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140476866	140476866	G	C	Biomarker=L514V;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453145	140453145	A	T	Biomarker=L597Q;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453145	140453145	A	C	Biomarker=L597R;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453145	140453146	CT	TC	Biomarker=L597S;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453146	140453146	G	C	Biomarker=L597V;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140477837	140477851	TAGGTGCTGTCACAT	-	Biomarker=N486_P490del;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140477836	140477850	GTAGGTGCTGTCACA	-	Biomarker=N486_T491delinsK;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453987	140453987	T	C	Biomarker=N581D;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453193	140453193	T	A	Biomarker=N581I;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453193	140453193	T	C	Biomarker=N581S;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453987	140453987	T	A	Biomarker=N581Y;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140494148	140494148	G	C	Biomarker=P367R;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140477826	140477840	CTGCTGAGGTGTAGG	-	Biomarker=P490_Q494del;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140501302	140501302	T	C	Biomarker=Q257R;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140481423	140481424	AG	GA	Biomarker=R462E;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140476887	140476887	-	CCTAAGTAC	Biomarker=R506_K507insVLR;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140439727	140439727	C	T	Biomarker=R671Q;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140534462	140534462	A	C	Biomarker=S151A;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140481409	140481409	A	C	Biomarker=S467A;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140481408	140481408	G	A	Biomarker=S467L;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140501351	140501351	T	G	Biomarker=T241P;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140477832	140477846	AGGTGTAGGTGCTGT	-	Biomarker=T488_P492del;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453139	140453139	G	A	Biomarker=T599I;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453139	140453139	G	C	Biomarker=T599R;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453136	140453136	-	CTGTTGCCT	Biomarker=T599_V600insEAT;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453136	140453136	-	CTGTTGTCT	Biomarker=T599_V600insETT;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453135	140453135	-	ACT	Biomarker=T599_V600insV;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453137	140453137	-	TGT	Biomarker=T599dup;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140481433	140481433	C	G	Biomarker=V459L;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140481397	140481397	C	A	Biomarker=V471F;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140477834	140477848	GTGTAGGTGCTGTCA	-	Biomarker=V487_P492delinsA;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453135	140453136	TG	AC	Biomarker=V600D;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453136	140453136	A	T	Biomarker=V600E;Evidence_level=3A|2A|1|1|2A|1;Drug=Cobimetinib|Encorafenib+Binimetinib+Cetuximab/Panitumumab+Dabrafenib+Trametinib|Dabrafenib+Trametinib|Dabrafenib/Dabrafenib+Trametinib/Encorafenib+Binimetinib/Trametinib/Vemurafenib/Vemurafenib+Cobimetinib|Vemurafenib|Dabrafenib+Trametinib;Tumor_type=Histiocytosis|Colorectal_Cancer|Anaplastic_Thyroid_Cancer|Melanoma|Hairy_Cell_Leukemia|Non_Small_Cell_Lung_Cancer
chr7	140453136	140453136	A	C	Biomarker=V600G;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453136	140453137	GT	AA	Biomarker=V600K;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453137	140453137	C	T	Biomarker=V600M;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453136	140453137	GT	AG	Biomarker=V600R;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453134	140453136	TCA	-	Biomarker=V600_K601delinsE;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453135	140453137	CAC	CATATA	Biomarker=V600delinsYM;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140481393	140481393	T	C	Biomarker=Y472C;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140494105	140508792	TACATCAATATTGACAGGTTCTATTGTGTTTATATGCACATTGGGAGCTGATGAGGATCGGTCTCGTTGCCCAAATTGATTTCGATGATCTTCATCTGCTGGTCGGAAGGGCTGTGGAATTGGAATGGATTTTGAAGGAGACGGACTGGTGAGAATTTGGGGCCTGGAAAAATGAAGTCATTGGAAGATAAGATTCAGAGTAACGATATAAAGGTAATAATATTTAAAAAGGAAGATAAAAGGATTTTCTTGTTTTTATATTCTCAAAATCATTAAAGCATTAAAAACCTAGCAGTAATGACTTTTAAAAGTATTAATTTAAAAATCCAATACTGCCAAAGCTGCTTTGCTCAAGTAGGCCCTCCAGGAACTATCAATGATAAGACCACTGATTCTTACCTGGAAAACACTAGGGAAATTTACTTATGGCTAGAAATTACCTGTGGCCATCAACTGAAGAAGTTCAACCTTTGAAGTTATATAAAAATGCTCTGAGAATGACTGAATATAATTTGCCATTTTTTTCTAACATTGTCTTGACATCTGAATTTACTAAAATGAAAATTTTACATATTAAGAAATTATAAATATTTTGAGAATACAAATGCATATTTCAGGACCTGAATGATGTACTTGTTCCTTTACAGGAGTTGAATGAAAATCCAGAACAATATTGAAAAATCCTTTTCAAATTCAGAAGATGATCCTCAGAGTGCCAATATCTCTCATATTCTGGATTTTTTATCATGCCCATTATTGATAACAGAGACACAAGAGAATCATATATTAACCACTAAAGCAAATATTTTTGAAAACTGCTATTTGGAAAACCACCAAAATGTTACATTTGTATGCTATTTGGAAAATCACCAAAATATGTTACATACCTATTTCGGTATGGTAGCTAAATAACATAGTCTATGATATCTCACCCTAAAATGAACCTGGCACTCACAGAGAACACTAAAGTTTTGAGACTAGATTGTAAACACTTGGAAGGATGTAGCCCCTCAGAAAGGGTATCCTAGGAGTGGGGAAATGAGTGTCACTTGATAGATGAGGTAAGCTGTCTCACTTAACTCCATCAGGACCAATGAATGGCTAAGTGCCAATAAGCTCTCTTCACATATTGGTTATCATTCCACCCTATTTTATGCAAACTAATTATTAGTGGTTACTAAGACACAGCTAGAAAGACAATGTTGAGGGAATAAAAAGACACTTTTGTGAGACGTGAGGAATGGGAAAAAAATATAGTAGGAAAGGAATGAATAAAGGTTTGAAGAGCCAAGGAAGCCTAACAGTGAAAGTCAGTCTCTGAATAAAACATGTCAGAATCTGAACCACACCAGTTCACAATTTTACTTCTTTGAAGCATATTATTAAAGATAAGGAAAGAAGTTTTGACTTCATGTGTTTATATTAATGAAATGAATCCACTTAGAATTGATATGCAAATAATAAAATATTATGTACTAAAAAAAAATTGGTATCGGCTCAATGAGAATTATAGGTAAGAAACAAGCCTTTAGGAAAATTAGCATGTTCCATCTAGGTCCTTTTTATTTTTTCTGATTATTGAGAAACTTTTGGTTTCTGACAGAGCTGTCTTTATTTTTGCTTTAGGTAGCCAAATATATGTCTATAGCTAGAAAATTTTAGGAGCAGGAAAAAGAATGCAAAAATGACATTAGTCAATAAAGTTTTAGAAAGGGCACTGACTGACTGACAACCATTTACAGGCTGATTTAAAGTCTCAAGGCAGGCCAGGTGCAGTGGCTCATGCCTGTAATCCCAGCACTTTTGGAGGCCAAAGCAGGTGGATCACCTGAGGTCAGGAGTTCAAGACCAGCCTGGCCAACATAGTAAAACCCTGTCTCTACTAAAAATACAAAAATTAGCTGGGTGTGGTGTTAAGGGCCTGTAATCCCAGCTACTCAGGGGGCTGAGGCAGGAGAATCACTTGAACCAGGGAGGCAGAGACTGCAGTGAGCCAAGATCACGTCTCTGCACTCGCCTGGGTGACAAAGTGAGACTCCATCTTAAAAAAAAAAAAAAAAGGCTTAAAATTGGAAAAAGTATGAATAACTAGAATTGCATAAGATAGTCTACTGTAATAATTGATCTGGGATAGGCAGAGATGGCAGTAAGTCACTTCTGAAACTCACCAAGTTAGGAATATGACAGAAACATGTAGTAGATAACAAATCAGAGTTAAGTATGCAAAAGACATTGGTCCAGAAGAAAAACAAAAACCAGATTTAATCTAAGACACTTCACTATCATATCTAAAGAATGTATATATTAGAAAATGATGATATCTGCGTATTATACAAAATCAGAGAAACTCAATTTGGTAGTTGGTATCTAATAGTTGTGTCTTGGTCCACCAAGTCAACTTCTCTAGCTTTCAGGGCAAGTACAAGGGAACACTTGAAGTGATCATAATCTGATGTCATTGAATATCTCAGCCATGTCCTAATTCTATGCTTAACGAAAACAGTCTTCTGATTATAATTTGATTTCCCATAAATCTCTTACAAAAGAAGAGTGAGTGGTGGCGCACACAACACAAGAAGTCTAATTTACATAACAGGTATATTTTTCACTGAAAAATATTACCTGGTATCCTGATTCAATTTTTTTTCTGATTTCAGTTAATACAAACCAGTATAACTCCCAATCTCATCATTTCTGGGAATCGATAAAATTACATTACCATACTGGGAAATTTTTCCACTAACCAAGGTAACTTATACCCTATGAAGTATCTTGGCAGTCGGCAAACTGGCTTTCTCCCAATGATACCTGTACCTATCTTGCAGTAAACCTCTTTAAAGCAGTACCAAATTAAAGACAAAAGGAATTTTAATTATAATACCCTTCAGCAAATTACCAGTTAGTTTAGATCTCATTCTTAATCTAGAATATTTAAAAGTTTTGAAAACTTTGGTCTGGTGATACGTACATTTTAAATGTTGACCTCTCACAAATTTATACATTCTACAGCATTTTTAAAAAGTAGAAAAGGAGGTATCTCTCACTTTGTATTCAAAACTGGGCAATGTATTGCTTCTCCAATATTTCTTGATTACATCCATTATTACACTTGTTTCATGACCATTATTATTGTTATCAGGACTAGTAACAAACTGCAAAAGAGTTTTGATACTGAACAAGATTGGCTTCTATCTTTACAGAGACAACCATATGGAGTTATGTCATAAAAACATCAGGAAAATGACTTACAGACAAGTTTGAACATCTTATCATTTGCTCAAGATCAGAATATATTTCAGTTCAGTTACCAATAAAATATTCATGGCACAGGCAAATGGTTTCTTAATTTTAAGATAGCATTCCTTCACTGGAAGGCAAATGTCCTGGATCATTACCATTATAAACCTTCAGAGAGGCCAAGCTAATTTCATTAGGGTGTTTTATAACTGCTCACAGAACTGGGACCTGCCATTAGAAAGGCATCATGGTCTACAGAATCTGTCAGGAGAAAATATTATAACCAAAAGATTAATTAAAAACCAACCAAATAATAACATTTTGATTTGACCATCTAAAAAAAACACAGCTGCACACAAGTAGTGATAGAGCCAACGGGAATAAAATGACTCCACTAGAAGAGATAACTGCTACAACCTGACAAGAGAACACAACGGCTGCATTTTCCAGTGTTCCAAATAGGTAAGTATACTCACTGCTTAAGACAAAATTCTTTTGCAAAATTTTCTAACCCATGAGATCACCAGAAAGGTTGGCTTTGTAAAAATTACAAAGTTGTACTGAAAATGTCAACTGATTTTGAAAAGATTTCTCTAGGTAGAAATCTGAAGAAATGGCATTACACTGTGAAGAGTGGGAGGAAGTAGGGTTAAAACTGACAATAAATATTTCTAATCTTAACATCTCAGGAATATTCTAGGACAGAATGCTGTATGGGGACTTTTTTTTTCTTTTTTTTGAGACGGAGTCTTGCTCTGTCACCCAGGCTGGAATGCAGTGACGTGATCTCGGCCCGCTACAAGCTCCACCTCCTGGGTTCACGCCATCCTCCTGACTCCTGAGTAGCTGGGACTACAGGCACCCGCCACCACGCCCGGCTAATTTTGTTTTTGTATTTTTAGTAGAGACGGGGTTTCACTGTGTTAGCCAGGATGGTCATGATCTCCCGACCTCGTGATCCGCCTGCCTCGGCCTCCCAAAGTGCTGGGATTACAGGAGTGAGCCACCGCGCCCGGCCTTTTTTTTTTTTTTTTTTTTTAAAGCATGTGCTTCCAGACGCAGCCTAAATAACGCTGCCCCAAATTCAATGTGAAAGAGTACACAGACCTGTGTCAGAAATGTTCCAAAGCTAATTAGGTGCAGTGTCTCACGCCTGTAATTCTAGCAGTTTGGGAGGCTGAGGCAGGAAGATCACCTGAGGCCAGGAGTTCGAGAAATGTTCCAAAGTAAACTGATACCCACTTAACTCATCTTTATTGTGTCTTCCTTTTTATTTCCTACTATGAAGCTTAAATGACGCCTTTGCATTATTTTTATTTTTTTGAGACAGAATCTCACCTGTCACCCAGGCTGGAGTGCAATGGTGCGATCTCAGCTCACTGCAACCTCCACCTCCCAGGTTCAAGTGATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGATTACAGGTGTGTGCCATCATGCCCAGCTAATTTTTTTTTTTTTGTATCTTTAGTAGAGACAGGGTTTCACCATGTTGGCCAGGCTGGTCTCGAACTCCTGACCTCGTGATCTGCCCGCCTCAGCCTCCCAAAGTGCTGGGATTACATGCGTGAACCACCGCACCCGGCTGCCTTTGCATTATTTTTAAAGTCACTTCTCAGCTTTATCCTCAACTGATTAATAATACTGTTCATTTTTTTCTTTTACGCTTTATGAATATCTATCCCTTTTCCATACTTCTAGCACTTGAACTTGTCTTCACTGCCTCTCTCAGTTTTCACTACCAACAACATCCTAGGTTGGCCTTCTTCACCCTAAATTTTCTGTCAATCCATCTGTATTTCACTGCTAATTGATTTTTTCTTTAAAGCCATTTTCATCAAGTTAGTAATCTGCTTAAAGACCTTTAAGTCTAAATTCTGGCCTCAATTCCAAGACTCTCCATAATCTGGTTTTACACATGGTAGTTCTTAAGTTAGATAAACCTTTCTTCACTAGCTTCTAAACCTAACATCTTCATTCCCTTTATATCTGTTTATTCCCTTTATATCTGTTGTTTCTCCATTCCCCTTTCACCATGCTTCTATTCCCTAGGCCCGTTCAGATTGTAGTAATTCTTTAAAGTCTAGTTCAAATACCACCTTCTTCATTAAGTTTTCCTGAGCACTCTCTTTTTCCTCACTATTCTTCCTTCTGTAAACATGAATACATTTATGTCCTCATCACATACTTCAATATACTCCATCATAAATTGTAGATTATAATTATATACTATTTTTACATTGTTTGCCATTGTCTCACATATCAATGCTTCTTCATAAGTGGAAGTCATATACTTCTATACCTAATAAAAGATGAACTCAAGGTGTAGACTCAAAATGATCTGTTGCATGATTTTTTCAGGACTGGTTCTGAAATAGTCTATGTCAGCTTTAATCCCACTTATTTGTACCAAATGCAAGTAAATATCTGACTGGTGTGATAAAATAAGTTATTTGGGGAAAAGATCCTTAATTTAAGCATTTAAATGTTGGAAATGTTTCTAATTAACCAGGAGATCCAAAAGAAAGCAGTTCAAGAAGCATGTCACTGAAGAGCAGAAGTCAAATCATACCCAATATTGATTTTTTCAGGACTGATTCTGAAATAGTCTATGTCAGCTTTAATCCCATTTATTTGTATCAAATGCATGTAAATATCTGAGTGGTATGATAAGTTATTTGGGGAAAAAGTCCTTAATTTAACAATTTAAACATTGGAAAGGTTTCTAATTAACCAGGAGATCCAAAAGAAAGCGGTTCAAGTAGCATGTCGCCCAAGAGCAGAAGTCAAACCATACCCAATAGAGTCCGAGGCGGGTGCGGAAGGGGATGATCCAGATGTTAGGGCAGTCTCTGCTAAGGACGCCTCTTCCTGTGGTATTGGGTGGTGTTCAAAGAACTTGGAGACAAACAGCAAACTGTGAGGCAAAACAAAACAAACCTAACTTGTGCAAAACCCAGAAGCTTCATATACCAAAATACATAGTTAACCAAAAAAACTGAGATCAAATTCCATTCTCAGAAACAACTGTTAAAATTCAATTAGTTGTATTTTTGTCTAAAGGCTTATTTTAAAAAAAATTGTATTGCACTTTCAAAGGCATGCTTATAACTTAAAACTAATCATTCAGTTCAGCAAATTTCTACATACTACAAGATGAAAATCATGCTTTATGGTTAAAGAATGAGAATAAAAAGTATCTACTGTAAATTAGGTGACATTATAATTTACTTAAAGTACAGAGTTAAGTTTTATTTGCTCAGGTGATCAAGAAAAGTAAGACTTTAACAGCAGCAGCACCAATGACACAAAAAGAGATAATAGACTCAGTCTAATCTATTAGAAAAACTGGCATACAGCAAAGAGAAATTTTAGAAAGAGATATATACTGGATACAAAAATTTTACATCTTACTCAAATAAATTGGGGGAAGGGAGCTGAATGGGGATGAAGGAGAGAGAGGAAGAATATAAACGTAATTTACAAAATAGCTAACAGAATCAGACTACCTGATCTGTGGTACAAAATCATAATGCTTAATTTAATTGAAACAACTCTCCCTCTCCTCCTAGAAACTATCCAAAAATGGTTTCTATGGGTTAGGGGTCTTGATTAATTAAACGATAATATAAAATATAAATTAACTGTATAGCTGAACCAGCATTACAATTTGGGAGAGAAATACTGTCCATTCCACATATTATTCTCTAACTACACTTAAAAAAAATTCTCTATAACAATCGTATGGAAGAAAAACCCTCACAGACTTTTAGACATCGTAGCTTCACATTAAGAAAATTTAAGTGTAAAATGGTAGGTAGAAAAGAGATATTTTTGGATTACTTACTCAAGTTGGTCATAATTAACACACATCAGTGGAACTTCTGTACTACAACGCTGGTGAAATTTATAACCACATGTTTGACAGCGGAAACCCTGGAAAAGCAGCTTTCGACAAAAGTCACAAAATGCTAAGGTGAAAAACGTTTTTCGTACCTGCAAAGTAAAAAATCACAGAGATTTCAAAAACTCACAAGAAAACTTTCTAGAAACTGACGTATCTACTCTCTTGTTTAAAATAACAAAGTTGTAATATATTTATATCATGAAACTCACATACTAAAGTACTATTATAAAATGAAAACCGGGGGTTCAAGATAATAGATGGACTACACATATTTATTTCCCACCCCACTATCTAACTTAAAAACCCAGAAGTTAAAAAATGAGAAATGAGTAAAAGGCTGGCAACTGATTTCAAGCTTGACAACATAAAAGTAAAAGTAGACATGAAAAGGAGGAGGAAACAGAGGTGAAAGGAAGAAGCCTATACTTTAATTATCATACAAAGAAGGGAGGTTAAGAAATGCCGACTGGTGTTGACGGAACAAGAAAGGCATATATTAAAGTTACAAAGGCACCCAATAGAAGAACCAAAAAACTACTAATAAAAATATTGGGGGAGAGGAGGGAGAGGAAGAACTATAAATGAGCTAATTCCTTATACAATCAGTAATCAGTATATGATATCTAAAGTTAATAAAGCAAGAAATTGTGGCTAAAAGATAATTGCAGTCATGTGTCACATAATGACACTTCAGTTAATCATGGACTTCATACCACAGTGGTCCCATAAGATTATAAAGGAGTTGAATAATTCCTATTGCCTAGTGATACCTTGAAGATCCTGACCTTGTGTAGACCTAGGCTAATGTGTATGTTTGTGTCTTTTTTTTTTTTTTTTTTTTTTTGAGACAGAGTCTGGCTCTGTCGCCCAGGCTGGAGTGCTGTGGCACGATCTCGGCTCACTGCAACCTCCACCTCCTGGTTCAAGTGATTCTCCTGCTTCAGCCTCCCGAGCAGCTGGGACCACAGGCACATGCCACTAGGCCTGGCTAATTTTCCTATTTTTTATTAGAGGAAGGGTTTCACCATGTTGACCAGGCTGGTCTTGAACTCCTGACCTCAGGTGATGCGTCTGCCTAGGCCTCCTCAAGTGCTGGGATTACAAACATGAGCCACCGTGTGCAGCTTGTGTCTTCATTTTTAACAGAAAAGTTTAAAAAGTAAAAAAGAAAAATTAAAAATTTTTAAAATAGAAGTTTATAGAATAAGCACATAAAATATTTTTGTATAGCTATATAATGTTTTTAAACTTTTGAAACTGTTATTTCAAGAGTCAAAAAGTTAAAAAAAATTAAACCTTAGTTTAATGTAAATTTTTTACTTTATAAACTTTTTAAAAAGAAAAATTTTAAAACTGTACTGTAGCCTAAGTGTACAATGTTTATCATAAAAGTCTACAGTAACAAATAGTAATGTCCTACGCCTTCACATTCACTCACCACTCACTCACCAGAGCAATTTCCAGTCCTAAAAGCTCTGTTCATATTAGGTATCCTACACAGGTAGACCATTTTTGATCTTTTATACTGTATTTTTACTGTACCTTTTCTACGTTTAGATACACAAACTTGCCACTGTGTTAAGGTTACCTACAGCATTCAGTTCAGTAACATTCCGTGCAGGTTATTAGCTTAGAAGCAATAGGCTCTACCATATAGCCTAGTTGTATAGTTAGGCTATACCATGTAGGCTTGTGTAAGCACATAACAAAATCACCATTGATGCATTTCTCAGAACATATCCCAGTCATCAGGCAATGTGTAACTGTATTTAGTAAGATGAAAATAATCACCAAAAGAGCTTAAAACAGAAACCATTAAAAATTAACAGTGAATTCCTCCAGAGTGGAATTGGGGGTGGGAGGGAGAGAGACTATAAATACAATCTACATAATAGCTAAAACAAAAACAAAAACAAAATAGCTGACAGAATCAGAACCCCTGATCTATGGTCCAAAAACATAATGGTTAACTTTGGATAAAAATGTAAAAACAATTATTTATAAAACTAGTAAGTAATCATATGAAAATTGAAACAGCTCTTCCTAATCTTACTAAAAAAAATAAGAAACAGAAAAATCACCTAAAAGACAATAAGATCTATTTTTTCTAACAAATGATCAATTTCTTAGAGGATTAGAATGTTTGGGCCACATAAACTTATTTGTGAACACTTCTCTAGGTGAAACTTAGAAGGCAACATGTTAAGAATTCCATGTCAAAGGCAAATGATGTAGAACATGAGTCACGTAACAGAACTGCACTAGGAAGAATCTATCCCACTAAAGCCAGAAATTGCTTAAAATATATTTATTTAGTGTATATAATAATAAGAAAATATAAGAATAAATATCAAAATGTGAGTGGCTACTTCAGAGTGGCGAGAGCATGGGTGACTTCTATTTCATTATTTGTTCTTTGCTCTGTATTCTTGAGATGGAGTCTCGCTCTGTCGCCCAGGTTGGAGTACAGTGGCAGGATCTCGGCCCACTGCAACCTCTGCCTCCTGGTTTCAAGTGATTCTCCTGCCTCAGCCTCCCAAGTAGCTGGGGACTACAGGCATGCACCACCATGCCTAGCTAACGTTTGTATTTTTTGGTGGAGATGGAGTTTCACCATGTTGGCCAGGCTGGTCTCAAACTCCTGACCTCAAGTGATCCGCCTGCCTCGTCTTCCCAGAGTGTTACAGACATGAGCCACCACACTCGGCCTCTATATTCTTAATTCATTTCAGTTTTTCAGAGATTTTTTTTTTGAGACAGAGTCTCACTGTCACCCAGGCCGGAGTGCAGTGGCACGATCTCGGCTCACTACAACCTCCACCTCCTGGATTCAAGCGATTTTCCTGCCTCAGCCTCCCGAGCAGCTAGGACTATAGGCGCACACCATCACACCTGGCTAATTTTTGTATTTTTAGTAGAGACAGGTTTTTTTTTTGGGGGGGGTGGTTAATACTTTTAATTACATGATTGTAATTATACAATTTCCACTCTTCAATATTTTGTATAAAACCAGTTACAACTCACAAGATTTTCAAATGAGACAGGATTTTACCAGGCTGGCCAGGCTGGTCTTGAACTCCTGACCTCGTGAGCTGCCCACCTTAGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACTGTGCCCAGTTTTTCAGAGTTTTAATCACAAATAATGATATTTTACATTATGACTCCATATATAACTGTATTCATACAACACTACTTACCCTGACTATATACAACATGAATTAGAACTTCCTAATCTATTCTGCTACATGTAAATTTTTTTATGATACATTAAATAGATTTCAACATCAAAAGTCTACTTTTCTTTTTCTTTTCTTTTTTTTTTGATAGGGTCTTGCTCTGTTGCCCAGGCTGGAGTATGGTGGCACAATCATGACTCACTGCAAAGTCTGCCTCCCAGGCTCAAGTTATCCTCCCACCTCAGGCTGAATAGCCAAGGCTATTGGTGCACACCACCATGCCCACCTACTTTTTGTATTTTTTTGGAGAGATGAGGTTTTGTCATGTTACCCAGGCTGGTCTTGAACTCTTGGGCTCAAGTGATCTGCCTGCCTCGGCCTCTCAAGGGATTAGAGGCATGAGCCACTGTGCCCAGCCAAAAGTCCATTTTCAATACACATTTATTTACACATTCTGTTCCATTAAGAATAGAAAGTTATTGAAAATATTTCAAGAAAATTACATCCTGATATATAATACATTCTGGCTTTTTGAGGACATTTAGTTTTAAAAGTGACTCTTATTTTCTTCACCTTTTTTCCTATGTATCACTTTCTAGGGGATATAAAACAGGTAAATGTCTATTTCTAATTGTGTTCTTTTTCCATTTGTCTCTGGATATACAAGAAATTTTAAAATCTTTAAAATTTTTTATGTGGCCATTATTCACCAAACCAAGTAGGTAGGTGACCAAAACAGCTGAAGGAAAGAAAACATGTGGATATGCATTTGATCATAAATTTTAAGCAATATATGCCTGTATCTGTAAGTATACCTTTGTCAATAAAGATGAGCACAGGAAGATATATCTTTCTTTTGGGTCACAGCTTACACTTAATCTAGTATCTGAGTATACATAAATATGTATGGCAAATTAGTGAGAGGCACAGTCAAGGTAATTTGCATGCATTAATTTGTAAGGTGTGGGGCTGTGTGAAGGAAGACACTGAGTGTCTGCAGAAAAAGGAGAAGGTTTGGATATAAAAGTTTCAAATCTTGTTTTCCCACTTCCCAGTTCCCAAGGACTCTTGGGATATAGAGAAATACTGAAGGGATTGCTTTTATAATATGAAACCATGAGGCATAAGCAGCCCTCCTTGAATAGCCAAGCAAAACCCAAGACAGCCAAGAACACTTTTCCTTTCTAAGCAGAACATAGGTTTTTGATCTTGCCTCTATATGGCACTCAGAGCAATCATTCTAACACACAAATCTAATCACATTTCTCCCCAAGCTTACAACTATTACATTTCTAATTATTTTACAGAAAAATCCAAATCTTTAATATGGCTAACAAGGATTTTCATGAGCTGGACTCTGCTTATTCTACCCACAACTCTTATTCTACCCACAATACTGTTAACAACCTACTCTTCAACCTTGTATCATCCATTCTGAACTTCTTTCAAAACTTTGAAAGGTAACATGCTTTCTTGCTCTTCCCTCTGTTTAGGGTACTCTTTACTTGATACTTACTTCCTCATCCATCAGGCCTAAGCTTAGATATTTCTGTCTCTGAGAAACCTTCCTAACTCCTCAAAAGCCAGGTTAGGAATCTCTGTGCATCTATAGAACTTTATACATATATAGTAATTATGAATGTTTATGAAAATTTATTAAATCTTCTCTCTACTCTATGGCAGTGACACTGTCTTATTCATTTGTCATATCCCTAGGTAAGATATGGTATTGGCAAATGGAAAGTTCTCAATAAAAATTTACTGGCAGGTATCCAACTGAGTGGTGACAATTTCCATACTCTGGAATCAATCTGCAGTTTGCTTTCACAATCCTTCTGTGGCAAGGACCTTCCTGAGGCATCATTTTAATACTATTTTCTCACACTTAGCAACTTAGGTCTTTCTTTTATCTCCTCATATTCAATTTCTAGCTAAGAAGAATTATTAAGAAACAGAGTAGTAATCACTATGAAATGTATGCTCAACTGTATTTGTATTCTTAAGAACTTAAATAAAAATGTTAAGATTTATCCACTTAAAATTCAACATGTTAAAAAATTATTTGCTGCACAGTAAAATTTGATTGACATTAGGTGTATCTTACACTTCTCCCAAAAAATGCCTTACAGAAACACAAACATGATTTCATTATTCACTACTAATGGAGGCTTGAAAGCATAAACCCCAAAGGAAATAATCTAATCAATCATCTGCTTTAAGAGCCCAGCTGGATTAATCACCAAGACACATGGGAAAACACTTGACGCCTAAAGGGTAGCAGTAATTATCCACCTAGAAAAAACTCTGGCCAAAATTCCATACATAGAGAAAAGTAAGAAATGTATTCCTGATTCAGAGACAACTTTTGGCTTCTGCCTGCCATTTTAGGGGATAAGTTCTCAAGTTCTATGTAGATCCTCATCTCTAAGGTGGAAAGGTCCCACATTCCGGGCCTTATGCTGGTGACCCTTAGGCTTATGCTAGGTTCTAGCAAATGCAAAAACCAGACAAAGAAAAAAGCCTCATGGAGAGTTTAATATCCAGCCATTCTATTTCCATTAACCTATCCTTCAGAAACACAAGGGTGTGTACAAGTGTGTCAAGATATATGCAGAAAGACCTTGTTTAGCCCTGTATGTAACAGATTTTTTATAATACAAAAACTTAAATGTCTATCAATAGAGAAATGGTTAAATATAATGAATTCCTATTCTTACGAATTATTACATAGTCATACTAAAATAAAGCCAGGTATACTGACATGAAAAGATGTCCGTGACATCCTGTTGAATTAAAAAAAAATAAGGCAAAGAATATCACATAGCATGGCTCTACTTTGATTTAAGAAAGGGAAAAGAAAAGAAAGTAATGAAGGAAAGAGAGAAAAAAAGAAAGGAAAAAACTTTAGGCTTACAGGTACAAGCACACGTTTGTGTACACAGAAAAAAGTTTGGAAGACAGAACAATAATCTGTTAATCTAAACAAATGTTGGCCTCTAGGAGGGTATTTTCACTTTTTTTACTTGACATACTTCTGCACTATTCAAAATTATCTTTTAACAATGCATACATTTTACTTTTTTAAATTAAAAAGAAAGTATAAAGATTAAAATTAAACTCTTGTTTAAATACAAGTTTTTAAAGAAAACAACTGATTTCAACTCAGGTAAAATGTCAGTTCCAAAATTACTCATCCATATTTCACATTCCCTAAATAAAAATTCATTCATTAAAATCTAAACATTTTTGACATTTCAAAAAAAAATGTAAAGATACATACAAAGTTGTGTGTTGTAAGTGGAACATTCTCCAACACTTCCACATGCAATTCTTCTCCAGTAAGCCAGGAAATATCAGTGTCCCAACCAATTGGTTTCTTCTCTCTGAAAAATGTAGACACAAGCCTTTCTTGGTTATTACACCTAAAAATATTCATATACCTCATGCTGAAGATATGAAAATTGGTTATCGAGGGGCTAGTAACAGTGAGGGAGGTTTGGCTCCCTAATATTCCATCGTTAGAAATTTAAATGGCAATAAATTAATTTTAAGTTTACCCCAAATAAATGTATCACTCTTGGACAAACAGCAGGGTAAAGAGATGTACTCTTTTCTTCAAGTCAGCTCCAGAAAAGACCTACAACAGCAGAAAATGGATTGTTCCTGGGGTCCAAAAAAAAAAAAAAAAAAAAAAAAAATCACAGGTACGGACTTATCTATCCATTCAAGGAAAAAGAGTACTCAAGGGACAGGGACAACATGCCCCCAAAATAATTTTTTTTTTTTTAAAGAGGATTCAAAATGTGAGGGTCTTGGAACAATGTTAGACACTTTCTGAAAGAAAAGTAGGTCAATATAAAATGTTAATTTTGATATACCTTTTGTGAAACTATGAGTTTGTATTAAAAATGGGAGGGGGGTAAGAGTCTATTATCCAAATAAATCACACTCTGAATGGTTCAAAAATTGTAAGAATCTCAAATTCCAAATAAAATCATTTGATCAAAGTAACAAACCCTACAGTCATATACAATTATTTAACTCCTCATATGGCCTACAGTATTTCTTCAGGCTAACTTAGTATTATTTTAATACTTTTTCCTAAAGTACACTTTCAATTCCCTAGGTTTTGGTAAAGATCCTAAGAAAACTTCAAAGTTTAATGTGTGATTTTCTTTTTAAACAAAATTTCACGTCACATACAAACCATACCCATCCTGAATTCTGTAAACAGCACAGCACTCTGGGATTAGACCTCTCATCATCAGTGCTTTCTTTAGACTGTCTCGGACTGTAACTCCACACCTTGCAGG	-	Biomarker=V169_D380del;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	140453136	140453137	AC	TT	Biomarker=V600K;Evidence_level=1;Drug=Dabrafenib+Trametinib/Encorafenib+Binimetinib/Trametinib/Vemurafenib+Cobimetinib;Tumor_type=Melanoma
chr17	41215920	41215920	G	T	Biomarker=A1708E;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209092	41209092	C	G	Biomarker=A1752P;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209091	41209091	G	A	Biomarker=A1752V;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41201179	41201179	C	T	Biomarker=A1789T;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41199660	41199660	C	T	Biomarker=A1823T;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41197760	41197760	C	G	Biomarker=A1843P;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41197760	41197760	C	T	Biomarker=A1843T;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215954	41215954	A	G	Biomarker=C1697R;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41276044	41276044	A	G	Biomarker=C24R;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41276043	41276043	C	T	Biomarker=C24Y;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41276034	41276035	TG	GC	Biomarker=C27A;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41267761	41267761	C	T	Biomarker=C39Y;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41267746	41267746	C	A	Biomarker=C44F;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41267746	41267746	C	T	Biomarker=C44Y;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41258546	41258546	A	C	Biomarker=C47G;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41258504	41258504	A	C	Biomarker=C61G;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41258495	41258495	A	C	Biomarker=C64G;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41219625	41219625	C	G	Biomarker=D1692H;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41219625	41219625	C	T	Biomarker=D1692N;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41219625	41219625	C	A	Biomarker=D1692Y;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209129	41209129	A	C	Biomarker=D1739E;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209130	41209130	T	C	Biomarker=D1739G;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209130	41209130	T	A	Biomarker=D1739V;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209131	41209131	C	A	Biomarker=D1739Y;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41222952	41222952	T	C	Biomarker=E1660G;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41197781	41197781	C	T	Biomarker=E1836K;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41267779	41267779	T	G	Biomarker=E33A;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215932	41215932	A	G	Biomarker=F1704S;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209146	41209146	A	G	Biomarker=F1734L;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209145	41209145	A	G	Biomarker=F1734S;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41203131	41203131	A	T	Biomarker=F1761I;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41203130	41203130	A	G	Biomarker=F1761S;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41222964	41222964	C	T	Biomarker=G1656D;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215926	41215926	C	T	Biomarker=G1706E;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209133	41209133	C	T	Biomarker=G1738E;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209134	41209134	C	T	Biomarker=G1738R;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209119	41209119	C	T	Biomarker=G1743R;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41203124	41203124	C	A	Biomarker=G1763V;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41203103	41203103	C	A	Biomarker=G1770V;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41201181	41201181	C	T	Biomarker=G1788D;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41201181	41201181	C	A	Biomarker=G1788V;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41199719	41199719	C	G	Biomarker=G1803A;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41219641	41219641	A	T	Biomarker=H1686Q;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41219642	41219642	T	C	Biomarker=H1686R;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209110	41209110	G	T	Biomarker=H1746N;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41267755	41267755	T	C	Biomarker=H41R;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41203115	41203115	A	C	Biomarker=I1766S;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41199707	41199707	A	C	Biomarker=I1807S;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41228529	41228529	T	C	Biomarker=K1487R;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215939	41215939	T	C	Biomarker=K1702E;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41234558	41234558	A	G	Biomarker=L1407P;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41222961	41222961	A	G	Biomarker=L1657P;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215929	41215929	A	G	Biomarker=L1705P;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41203121	41203121	A	G	Biomarker=L1764P;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41201205	41201205	A	G	Biomarker=L1780P;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41197726	41197726	A	G	Biomarker=L1854P;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41276049	41276049	A	G	Biomarker=L22S;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41223049	41223049	T	C	Biomarker=M1628V;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41222976	41222976	A	T	Biomarker=M1652K;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41219633	41219633	A	C	Biomarker=M1689R;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41219633	41219633	A	G	Biomarker=M1689T;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41203088	41203089	AT	GA	Biomarker=M1775E;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41203088	41203088	A	T	Biomarker=M1775K;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41203088	41203088	A	C	Biomarker=M1775R;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41276061	41276061	A	G	Biomarker=M18T;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41276112	41276112	A	C	Biomarker=M1R;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209100	41209100	G	C	Biomarker=P1749R;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41199693	41199693	G	C	Biomarker=P1812A;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209078	41209080	CAG	TGT	Biomarker=Q1756C;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41199695	41199695	T	C	Biomarker=Q1811R;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41228505	41228505	C	T	Biomarker=R1495K;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215947	41215947	C	A	Biomarker=R1699L;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215947	41215947	C	T	Biomarker=R1699Q;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215948	41215948	G	A	Biomarker=R1699W;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209094	41209094	C	G	Biomarker=R1751P;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209088	41209088	C	G	Biomarker=R1753T;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41197783	41197783	C	G	Biomarker=R1835P;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41244057	41244057	C	A	Biomarker=S1164I;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41222967	41222967	G	A	Biomarker=S1655F;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215900	41215900	T	A	Biomarker=S1715C;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215899	41215899	C	T	Biomarker=S1715N;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215898	41215898	G	C	Biomarker=S1715R;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215378	41215378	G	A	Biomarker=S1722F;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41197765	41197766	AG	GC	Biomarker=S1841A;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41197765	41197765	C	T	Biomarker=S1841N;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41197764	41197764	A	C	Biomarker=S1841R;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41219646	41219646	T	C	Biomarker=T1685A;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41219645	41219645	G	A	Biomarker=T1685I;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41219627	41219627	G	A	Biomarker=T1691I;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41219627	41219627	G	T	Biomarker=T1691K;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215945	41215945	T	C	Biomarker=T1700A;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41203094	41203094	G	A	Biomarker=T1773I;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41267767	41267767	G	C	Biomarker=T37R;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41222974	41222974	C	T	Biomarker=V1653M;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41219635	41219637	AAC	-	Biomarker=V1688del;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215957	41215957	C	G	Biomarker=V1696L;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215905	41215905	A	G	Biomarker=V1713A;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215902	41215902	A	C	Biomarker=V1714G;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209139	41209139	A	G	Biomarker=V1736A;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209139	41209139	A	C	Biomarker=V1736G;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41209124	41209124	A	C	Biomarker=V1741G;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41199702	41199702	C	A	Biomarker=V1809F;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41199698	41199698	A	C	Biomarker=V1810G;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41197789	41197789	A	T	Biomarker=V1833E;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41197790	41197790	C	T	Biomarker=V1833M;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41197774	41197774	A	T	Biomarker=V1838E;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215389	41215389	C	A	Biomarker=W1718C;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215390	41215390	C	A	Biomarker=W1718L;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215390	41215390	C	G	Biomarker=W1718S;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41197776	41197776	C	A	Biomarker=W1837C;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41197778	41197778	A	C	Biomarker=W1837G;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41197778	41197778	A	T	Biomarker=W1837R;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215936	41215936	A	G	Biomarker=Y1703H;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41215935	41215935	T	G	Biomarker=Y1703S;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41197728	41197728	G	T	Biomarker=Y1853*;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr17	41197729	41197729	T	C	Biomarker=Y1853C;Evidence_level=1|2A|1|2A|2A;Drug=Niraparib/Rucaparib|Olaparib|Niraparib/Rucaparib|Olaparib|Olaparib/Talazoparib;Tumor_type=Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Breast_Cancer
chr13	32914031	32914162	GCCAGTGGTAAAATCGTTTGTGTTTCACATGAAACAATTAAAAAAGTGAAAGACATATTTACAGACAGTTTCAGTAAAGTAATTAAGGAAAACAACGAGAATAAATCAAAAATTTGCCAAACGAAAATTATG	-	Biomarker=A1847_M1890del;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32936661	32936661	G	C	Biomarker=A2603P;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32944563	32944563	G	C	Biomarker=A2786P;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32900691	32900691	A	G	Biomarker=D191G;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32937507	32937507	A	C	Biomarker=D2723A;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32937507	32937507	A	G	Biomarker=D2723G;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32937506	32937506	G	C	Biomarker=D2723H;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32937507	32937507	A	T	Biomarker=D2723V;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32954244	32954244	A	G	Biomarker=D3073G;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32968854	32968854	C	G	Biomarker=D3095E;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32912634	32912636	AAG	-	Biomarker=E1382del;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32937327	32937327	A	T	Biomarker=E2663V;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32945144	32945144	G	A	Biomarker=E2847K;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32953937	32953937	G	A	Biomarker=E3002K;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32931945	32931945	T	C	Biomarker=F2562L;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32936779	32936779	T	C	Biomarker=F2642S;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32900636	32900636	G	T	Biomarker=G173C;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32932014	32932014	G	A	Biomarker=G2585R;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32932048	32932048	G	A	Biomarker=G2596E;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32932047	32932047	G	A	Biomarker=G2596R;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32936680	32936680	G	A	Biomarker=G2609D;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32936680	32936680	G	T	Biomarker=G2609V;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32937582	32937582	G	A	Biomarker=G2748D;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32944585	32944585	G	A	Biomarker=G2793E;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32944584	32944584	G	A	Biomarker=G2793R;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32953941	32953941	G	A	Biomarker=G3003E;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32954253	32954253	G	A	Biomarker=G3076E;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32954252	32954252	G	A	Biomarker=G3076R;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32954253	32954253	G	T	Biomarker=G3076V;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32936722	32936722	A	G	Biomarker=H2623R;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32936733	32936733	A	T	Biomarker=I2627F;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32937362	32937362	A	G	Biomarker=I2675V;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32911565	32911570	AAGAAG	AACTAA	Biomarker=K1025_K1026delinsN*;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32914106	32914106	A	T	Biomarker=K1872*;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32930621	32930621	A	G	Biomarker=K2498E;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32936742	32936742	A	C	Biomarker=K2630Q;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32930658	32930658	T	C	Biomarker=L2510P;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32936794	32936794	T	C	Biomarker=L2647P;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32936812	32936812	T	C	Biomarker=L2653P;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32937396	32937396	T	C	Biomarker=L2686P;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32937402	32937402	T	C	Biomarker=L2688P;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32937501	32937501	T	A	Biomarker=L2721H;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32944582	32944582	T	C	Biomarker=L2792P;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32968943	32968943	T	A	Biomarker=L3125H;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32968940	32968940	A	T	Biomarker=N3124I;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32931943	32931943	A	C	Biomarker=Q2561P;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32936818	32936818	A	G	Biomarker=Q2655R;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32953472	32953472	C	A	Biomarker=Q2925K;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32900639	32900639	C	T	Biomarker=R174C;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32921033	32921033	G	A	Biomarker=R2336H;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32921033	32921033	G	C	Biomarker=R2336P;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32932066	32932066	G	C	Biomarker=R2602T;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32936830	32936830	G	A	Biomarker=R2659K;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32936830	32936830	G	C	Biomarker=R2659T;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32944558	32944558	G	A	Biomarker=R2784Q;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32944557	32944557	C	T	Biomarker=R2784W;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32945129	32945129	C	T	Biomarker=R2842C;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32954180	32954180	C	T	Biomarker=R3052W;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32899321	32899321	G	T	Biomarker=S142I;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32913991	32914167	TAGTAATAATTTTGAGGTAGGGCCACCTGCATTTAGGATAGCCAGTGGTAAAATCGTTTGTGTTTCACATGAAACAATTAAAAAAGTGAAAGACATATTTACAGACAGTTTCAGTAAAGTAATTAAGGAAAACAACGAGAATAAATCAAAAATTTGCCAAACGAAAATTATGGCAGG	-	Biomarker=S1834_G1892del;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32914095	32914121	ACAGTTTCAGTAAAGTAATTAAGGAAA	-	Biomarker=S1869_N1877del;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32914103	32914171	AGTAAAGTAATTAAGGAAAACAACGAGAATAAATCAAAAATTTGCCAAACGAAAATTATGGCAGGTTGT	-	Biomarker=S1871_C1893del;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32900706	32900706	G	A	Biomarker=S196N;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32900736	32900736	C	G	Biomarker=S206C;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32937348	32937348	C	T	Biomarker=S2670L;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32937411	32937411	C	T	Biomarker=S2691F;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32912393	32912395	ACT	-	Biomarker=T1302del;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32913935	32914174	ACTAGCTCTTCACCCTGCAAAAATAAAAATGCAGCCATTAAATTGTCCATATCTAATAGTAATAATTTTGAGGTAGGGCCACCTGCATTTAGGATAGCCAGTGGTAAAATCGTTTGTGTTTCACATGAAACAATTAAAAAAGTGAAAGACATATTTACAGACAGTTTCAGTAAAGTAATTAAGGAAAACAACGAGAATAAATCAAAAATTTGCCAAACGAAAATTATGGCAGGTTGTTAC	-	Biomarker=T1815_Y1894del;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32930673	32930673	C	T	Biomarker=T2515I;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32937504	32937504	C	G	Biomarker=T2722R;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32913859	32914479	AGTAATATCCAATGTAAAAGATGCAAATGCATACCCACAAACTGTAAATGAAGATATTTGCGTTGAGGAACTTGTGACTAGCTCTTCACCCTGCAAAAATAAAAATGCAGCCATTAAATTGTCCATATCTAATAGTAATAATTTTGAGGTAGGGCCACCTGCATTTAGGATAGCCAGTGGTAAAATCGTTTGTGTTTCACATGAAACAATTAAAAAAGTGAAAGACATATTTACAGACAGTTTCAGTAAAGTAATTAAGGAAAACAACGAGAATAAATCAAAAATTTGCCAAACGAAAATTATGGCAGGTTGTTACGAGGCATTGGATGATTCAGAGGATATTCTTCATAACTCTCTAGATAATGATGAATGTAGCACGCATTCACATAAGGTTTTTGCTGACATTCAGAGTGAAGAAATTTTACAACATAACCAAAATATGTCTGGATTGGAGAAAGTTTCTAAAATATCACCTTGTGATGTTAGTTTGGAAACTTCAGATATATGTAAATGTAGTATAGGGAAGCTTCATAAGTCAGTCTCATCTGCAAATACTTGTGGGATTTTTAGCACAGCAAGTGGAAAATCTGTCCAGGTATCAGATGCTTCATTACAAAACGC	-	Biomarker=V1790_A1996del;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32914004	32914192	GAGGTAGGGCCACCTGCATTTAGGATAGCCAGTGGTAAAATCGTTTGTGTTTCACATGAAACAATTAAAAAAGTGAAAGACATATTTACAGACAGTTTCAGTAAAGTAATTAAGGAAAACAACGAGAATAAATCAAAAATTTGCCAAACGAAAATTATGGCAGGTTGTTACGAGGCATTGGATGATTCA	-	Biomarker=V1839_E1901del;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32900750	32900750	G	A	Biomarker=V211I;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32936732	32936732	G	T	Biomarker=W2626C;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32937513	32937513	G	T	Biomarker=W2725L;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32944569	32944569	T	A	Biomarker=W2788R;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32944570	32944570	G	C	Biomarker=W2788S;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32937317	32937317	T	G	Biomarker=Y2660D;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr13	32937516	32937516	A	G	Biomarker=Y2726C;Evidence_level=2A|2A|2A|1|1;Drug=Olaparib/Talazoparib|Olaparib|Olaparib|Niraparib/Rucaparib|Niraparib/Rucaparib;Tumor_type=Breast_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer|Peritoneal_Serous_Carcinoma|Ovarian_Cancer
chr9	21974721	21974721	C	G	Biomarker=A36P;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971179	21971180	GC	AG	Biomarker=A60R;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971179	21971179	G	A	Biomarker=A60V;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971156	21971156	C	T	Biomarker=A68T;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971036	21971036	C	G	Biomarker=D108H;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971036	21971036	C	T	Biomarker=D108N;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21970901	21970901	C	G	Biomarker=D153H;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971138	21971138	C	T	Biomarker=D74N;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971138	21971138	C	A	Biomarker=D74Y;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971107	21971107	T	C	Biomarker=D84G;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971108	21971108	C	G	Biomarker=D84H;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971108	21971108	C	T	Biomarker=D84N;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971107	21971107	T	A	Biomarker=D84V;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971108	21971108	C	A	Biomarker=D84Y;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971152	21971152	T	C	Biomarker=E69G;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971096	21971096	C	T	Biomarker=E88K;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971057	21971057	C	A	Biomarker=G101W;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21974759	21974759	C	T	Biomarker=G23D;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21974723	21974723	C	G	Biomarker=G35A;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21974724	21974724	C	T	Biomarker=G35R;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21974723	21974723	C	A	Biomarker=G35V;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971159	21971159	C	G	Biomarker=G67R;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971159	21971159	C	T	Biomarker=G67S;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971111	21971111	G	T	Biomarker=H83N;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971111	21971111	G	A	Biomarker=H83Y;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21974681	21974681	A	C	Biomarker=I49S;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21974780	21974780	A	G	Biomarker=L16P;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21974732	21974732	A	G	Biomarker=L32P;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971068	21971068	A	C	Biomarker=L97R;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971199	21971199	C	G	Biomarker=M53I;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971146	21971146	T	A	Biomarker=N71I;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971145	21971145	G	C	Biomarker=N71K;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971146	21971146	T	C	Biomarker=N71S;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971017	21971017	G	A	Biomarker=P114L;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971018	21971018	G	A	Biomarker=P114S;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21974684	21974684	G	A	Biomarker=P48L;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971116	21971116	G	A	Biomarker=P81L;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971117	21971117	G	T	Biomarker=P81T;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21974679	21974679	G	A	Biomarker=Q50*;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21974678	21974678	T	G	Biomarker=Q50P;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971024	21971024	G	C	Biomarker=R112G;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21974756	21974756	C	G	Biomarker=R24P;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971119	21971119	C	A	Biomarker=R80L;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971119	21971119	C	G	Biomarker=R80P;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971098	21971098	C	A	Biomarker=R87L;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971098	21971098	C	G	Biomarker=R87P;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971099	21971099	G	A	Biomarker=R87W;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971062	21971062	C	G	Biomarker=R99P;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971191	21971191	C	A	Biomarker=S56I;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971129	21971129	T	G	Biomarker=T77P;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21970981	21970981	A	T	Biomarker=V126D;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr9	21971182	21971182	A	C	Biomarker=V59G;Evidence_level=4;Drug=Abemaciclib/Palbociclib/Ribociclib;Tumor_type=All_Solid_Tumors
chr7	55221822	55221822	C	T	Biomarker=A289V;Evidence_level=4;Drug=Lapatinib;Tumor_type=Glioma
chr7	55242478	55242478	G	C	Biomarker=A750P;Evidence_level=4;Drug=Afatinib/Erlotinib/Gefitinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr7	55248991	55248991	-	TTTCAAGAGGCA	Biomarker=A763_Y764insFQEA;Evidence_level=2A;Drug=Afatinib/Erlotinib/Gefitinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr7	55249091	55249091	T	G	Biomarker=C797G;Evidence_level=R2;Drug=Osimertinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr7	55249091	55249091	T	A	Biomarker=C797S;Evidence_level=R2;Drug=Osimertinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr7	55242511	55242511	G	T	Biomarker=D761Y;Evidence_level=R2|4;Drug=Gefitinib|Osimertinib;Tumor_type=Non_Small_Cell_Lung_Cancer|Non_Small_Cell_Lung_Cancer
chr7	55241679	55241681	AAC	-	Biomarker=E709_T710delinsD;Evidence_level=3A;Drug=Afatinib/Erlotinib/Gefitinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr7	55241677	55241677	G	A	Biomarker=E709K;Evidence_level=3A;Drug=Afatinib/Erlotinib/Gefitinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr7	55242469	55242470	TT	CC	Biomarker=L747P;Evidence_level=4;Drug=Afatinib/Erlotinib/Gefitinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr7	55259439	55259439	T	G	Biomarker=L833V;Evidence_level=3A;Drug=Afatinib/Erlotinib/Gefitinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr7	55259515	55259515	T	G	Biomarker=L858R;Evidence_level=1;Drug=Afatinib/Dacomitinib/Erlotinib/Gefitinib/Osimertinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr7	55259524	55259524	T	A	Biomarker=L861Q;Evidence_level=1;Drug=Afatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr7	55259524	55259524	T	G	Biomarker=L861R;Evidence_level=3A;Drug=Afatinib/Erlotinib/Gefitinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr7	55211080	55211080	G	A	Biomarker=R108K;Evidence_level=4;Drug=Lapatinib;Tumor_type=Glioma
chr7	55249005	55249005	G	T	Biomarker=S768I;Evidence_level=1;Drug=Afatinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr7	55221743	55221743	A	C	Biomarker=T263P;Evidence_level=4;Drug=Lapatinib;Tumor_type=Glioma
chr7	55249071	55249071	C	T	Biomarker=T790M;Evidence_level=R1|1;Drug=Afatinib/Erlotinib/Gefitinib|Osimertinib;Tumor_type=Non_Small_Cell_Lung_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37871997	37871997	G	A	Biomarker=A440T;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37876071	37876072	GC	TT	Biomarker=A644F;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879834	37879834	C	T	Biomarker=A710V;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880996	37880996	-	TATGTAATGGCA	Biomarker=A775_G776insYVMA;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37868210	37868210	T	C	Biomarker=C311R;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37868279	37868279	T	A	Biomarker=C334S;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37873724	37873724	G	A	Biomarker=C630Y;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37866662	37866662	G	C	Biomarker=D277H;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37866662	37866662	G	T	Biomarker=D277Y;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880262	37880262	A	C	Biomarker=D769A;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880261	37880261	G	C	Biomarker=D769H;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880261	37880261	G	T	Biomarker=D769Y;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881093	37881093	G	A	Biomarker=D808N;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881132	37881132	G	A	Biomarker=D821N;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37866626	37866626	G	A	Biomarker=E265K;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37868241	37868241	A	G	Biomarker=E321G;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37876074	37876076	GAG	TTT	Biomarker=E645F;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879702	37879702	G	A	Biomarker=E693K;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879854	37879854	G	A	Biomarker=E717K;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879861	37879861	A	G	Biomarker=E719G;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879860	37879860	G	A	Biomarker=E719K;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880981	37880981	-	GCATATGTAATG	Biomarker=E770_A771insAYVM;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881105	37881105	G	A	Biomarker=E812K;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880977	37881162	AGGAAGCATACGTGATGGCTGGTGTGGGCTCCCCATATGTCTCCCGCCTTCTGGGCATCTGCCTGACATCCACGGTGCAGCTGGTGACACAGCTTATGCCCTATGGCTGCCTCTTAGACCATGTCCGGGAAAACCGCGGACGCCTGGGCTCCCAGGACCTGCTGAACTGGTGTATGCAGATTGCCA	-	Biomarker=E770_K831del;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37866359	37866359	G	T	Biomarker=G222C;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37866707	37866707	G	C	Biomarker=G292R;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37868205	37868205	G	C	Biomarker=G309A;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37868205	37868205	G	A	Biomarker=G309E;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879604	37879604	G	A	Biomarker=G660D;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879603	37879603	G	C	Biomarker=G660R;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880997	37880997	G	A	Biomarker=G776S;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880998	37880998	G	T	Biomarker=G776V;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880997	37880997	-	GTGTAGGTT	Biomarker=G776_V777insVGC;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880999	37880999	-	TATGTAATGGCA	Biomarker=G776_V777insYVMA;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880997	37880999	GGT	CTTTGT	Biomarker=G776delinsLC;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880997	37880999	GGT	GTATGT	Biomarker=G776delinsVC;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881002	37881002	-	GGCTCCCCA	Biomarker=G778_P780dup;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881005	37881005	-	GGT	Biomarker=G778_S779insG;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881440	37881440	C	T	Biomarker=H878Y;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879669	37879670	AT	GG	Biomarker=I682G;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880257	37880257	C	G	Biomarker=I767M;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879576	37879576	C	G	Biomarker=L651V;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879613	37879613	T	C	Biomarker=L663P;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879645	37879645	C	G	Biomarker=L674V;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879881	37879881	C	T	Biomarker=L726F;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879881	37879881	C	A	Biomarker=L726I;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880219	37880220	TT	CC	Biomarker=L755P;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880220	37880220	T	C	Biomarker=L755S;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880219	37880227	TTGAGGGAA	AGC	Biomarker=L755_E757delinsS;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880219	37880233	TTGAGGGAAAACACA	-	Biomarker=L755_T759del;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881024	37881024	C	T	Biomarker=L785F;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881329	37881329	C	G	Biomarker=L841V;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881404	37881404	C	A	Biomarker=L866M;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881414	37881414	T	G	Biomarker=L869R;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881977	37881977	C	A	Biomarker=L915M;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880990	37880990	-	ATGGCATATGTA	Biomarker=M774_A775insAYVM;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881378	37881378	A	G	Biomarker=N857S;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879573	37879573	C	T	Biomarker=P650S;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881010	37881010	C	T	Biomarker=P780L;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881011	37881011	-	GGTAGCCCT	Biomarker=P780_Y781insGSP;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879831	37879831	A	T	Biomarker=Q709L;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37866344	37866344	C	T	Biomarker=R217C;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37872138	37872138	C	T	Biomarker=R487W;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879655	37879655	G	T	Biomarker=R677L;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879658	37879658	G	A	Biomarker=R678Q;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879657	37879657	C	T	Biomarker=R678W;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879673	37879673	G	A	Biomarker=R683Q;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881021	37881021	C	T	Biomarker=R784C;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881616	37881616	C	T	Biomarker=R896C;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37883103	37883103	C	G	Biomarker=S1002R;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37868208	37868208	C	T	Biomarker=S310F;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37868208	37868208	C	A	Biomarker=S310Y;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37868282	37868282	A	T	Biomarker=S335C;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37876087	37876087	G	C	Biomarker=S649T;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879583	37879583	C	G	Biomarker=S653C;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879592	37879592	C	G	Biomarker=S656C;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881018	37881018	T	C	Biomarker=S783P;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879681	37879681	A	G	Biomarker=T686A;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879903	37879903	C	T	Biomarker=T733I;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881064	37881065	CA	TG	Biomarker=T798M;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881392	37881392	A	G	Biomarker=T862A;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879601	37879602	TT	AG	Biomarker=V659E;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879601	37879601	T	G	Biomarker=V659G;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37879600	37879602	GTT	AAG	Biomarker=V659K;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880989	37880989	T	C	Biomarker=V773A;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881001	37881001	T	C	Biomarker=V777A;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881000	37881000	G	C	Biomarker=V777L;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881000	37881000	G	A	Biomarker=V777M;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881051	37881051	G	A	Biomarker=V794M;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881324	37881324	T	G	Biomarker=V839G;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881332	37881332	G	A	Biomarker=V842I;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37880984	37880984	-	TACGTGATGGCT	Biomarker=Y772_A775dup;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr17	37881078	37881078	T	A	Biomarker=Y803N;Evidence_level=3A|3A|2A;Drug=Neratinib|Neratinib|Ado_Trastuzumab_Emtansine;Tumor_type=Non_Small_Cell_Lung_Cancer|Breast_Cancer|Non_Small_Cell_Lung_Cancer
chr19	45855507	45855507	G	C	Biomarker=A717G;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45860928	45860928	C	T	Biomarker=D423N;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45858929	45858929	C	A	Biomarker=D513Y;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45856345	45856345	G	C	Biomarker=D609E;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45856346	45856346	T	C	Biomarker=D609G;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45856532	45856532	C	T	Biomarker=E576K;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45856355	45856355	T	C	Biomarker=E606G;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45872197	45872197	C	G	Biomarker=E79D;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45871992	45871992	C	G	Biomarker=E86Q;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45856352	45856352	C	G	Biomarker=G607A;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45855816	45855816	C	G	Biomarker=G665A;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45855817	45855817	C	A	Biomarker=G665C;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45855835	45855835	G	A	Biomarker=H659Y;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45860626	45860626	G	C	Biomarker=L461V;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45872387	45872387	T	C	Biomarker=M42V;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45867687	45867687	T	C	Biomarker=N238S;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45860619	45860619	G	A	Biomarker=P463L;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45860548	45860548	G	A	Biomarker=R487W;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45856370	45856370	C	T	Biomarker=R601Q;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45856015	45856015	G	A	Biomarker=R631C;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45855610	45855610	G	A	Biomarker=R683W;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45867571	45867571	G	A	Biomarker=S246F;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45872380	45872380	G	A	Biomarker=S44L;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45872374	45872374	G	C	Biomarker=T46S;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45860556	45860556	G	A	Biomarker=T484M;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45867584	45867584	C	A	Biomarker=V242F;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45858047	45858047	C	T	Biomarker=V536M;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45873455	45873455	T	C	Biomarker=Y14C;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45867774	45867774	T	C	Biomarker=Y209C;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45873425	45873425	T	C	Biomarker=Y24C;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr19	45872219	45872219	T	C	Biomarker=Y72C;Evidence_level=3A;Drug=Cisplatin;Tumor_type=Bladder_Cancer
chr6	152419926	152419926	A	G	Biomarker=D538G;Evidence_level=3A;Drug=AZD9496/Fulvestrant;Tumor_type=Breast_Cancer
chr6	152332832	152332832	G	C	Biomarker=E380Q;Evidence_level=3A;Drug=AZD9496/Fulvestrant;Tumor_type=Breast_Cancer
chr6	152415555	152415555	C	G	Biomarker=L469V;Evidence_level=3A;Drug=AZD9496/Fulvestrant;Tumor_type=Breast_Cancer
chr6	152419920	152419920	T	A	Biomarker=L536H;Evidence_level=3A;Drug=AZD9496/Fulvestrant;Tumor_type=Breast_Cancer
chr6	152419920	152419920	T	C	Biomarker=L536P;Evidence_level=3A;Drug=AZD9496/Fulvestrant;Tumor_type=Breast_Cancer
chr6	152419920	152419921	TC	AA	Biomarker=L536Q;Evidence_level=3A;Drug=AZD9496/Fulvestrant;Tumor_type=Breast_Cancer
chr6	152419920	152419920	T	G	Biomarker=L536R;Evidence_level=3A;Drug=AZD9496/Fulvestrant;Tumor_type=Breast_Cancer
chr6	152415537	152415537	T	C	Biomarker=S463P;Evidence_level=3A;Drug=AZD9496/Fulvestrant;Tumor_type=Breast_Cancer
chr6	152382152	152382154	TGG	-	Biomarker=V422del;Evidence_level=3A;Drug=AZD9496/Fulvestrant;Tumor_type=Breast_Cancer
chr6	152419923	152419923	A	G	Biomarker=Y537C;Evidence_level=3A;Drug=AZD9496/Fulvestrant;Tumor_type=Breast_Cancer
chr6	152419922	152419922	T	A	Biomarker=Y537N;Evidence_level=3A;Drug=AZD9496/Fulvestrant;Tumor_type=Breast_Cancer
chr6	152419923	152419923	A	C	Biomarker=Y537S;Evidence_level=3A;Drug=AZD9496/Fulvestrant;Tumor_type=Breast_Cancer
chr7	148506437	148506437	G	A	Biomarker=A692V;Evidence_level=3A;Drug=Tazemetostat;Tumor_type=Follicular_Lymphoma
chr7	148511174	148511174	G	C	Biomarker=C576W;Evidence_level=3A;Drug=Tazemetostat;Tumor_type=Follicular_Lymphoma
chr7	148506444	148506444	G	A	Biomarker=R690C;Evidence_level=3A;Drug=Tazemetostat;Tumor_type=Follicular_Lymphoma
chr7	148508727	148508727	T	C	Biomarker=Y646C;Evidence_level=3A;Drug=Tazemetostat;Tumor_type=Follicular_Lymphoma
chr7	148508727	148508727	T	A	Biomarker=Y646F;Evidence_level=3A;Drug=Tazemetostat;Tumor_type=Follicular_Lymphoma
chr7	148508728	148508728	A	G	Biomarker=Y646H;Evidence_level=3A;Drug=Tazemetostat;Tumor_type=Follicular_Lymphoma
chr7	148508728	148508728	A	T	Biomarker=Y646N;Evidence_level=3A;Drug=Tazemetostat;Tumor_type=Follicular_Lymphoma
chr7	148508727	148508727	T	G	Biomarker=Y646S;Evidence_level=3A;Drug=Tazemetostat;Tumor_type=Follicular_Lymphoma
chr7	148506167	148506167	A	C	Biomarker=Y731D;Evidence_level=3A;Drug=Tazemetostat;Tumor_type=Follicular_Lymphoma
chr8	38272308	38272308	T	C	Biomarker=K687E;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr8	38274849	38274849	G	C	Biomarker=N577K;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr8	38273561	38273561	C	T	Biomarker=V592M;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123274774	123274774	A	G	Biomarker=C382R;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123325027	123325027	C	A	Biomarker=D101Y;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123256215	123256215	T	C	Biomarker=E565G;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123244913	123244913	C	T	Biomarker=E731K;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123279605	123279605	A	C	Biomarker=F276C;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123258042	123258042	T	C	Biomarker=I547V;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123258105	123258105	T	C	Biomarker=K526E;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123247568	123247568	T	G	Biomarker=K641N;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123247569	123247569	T	C	Biomarker=K641R;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123247514	123247514	C	G	Biomarker=K659N;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123256058	123256058	C	A	Biomarker=L617F;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123256060	123256060	A	T	Biomarker=L617M;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123274746	123274746	A	C	Biomarker=M391R;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123258076	123258076	C	G	Biomarker=M535I;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123258070	123258070	C	G	Biomarker=M537I;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123258036	123258036	T	G	Biomarker=N549H;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123258034	123258034	A	C	Biomarker=N549K;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123258035	123258035	T	C	Biomarker=N549S;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123258035	123258035	T	G	Biomarker=N549T;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123279674	123279674	G	C	Biomarker=P253R;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123310821	123310821	G	A	Biomarker=R203C;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123279680	123279680	C	T	Biomarker=R251Q;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123246893	123246893	T	C	Biomarker=R678G;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123279677	123279677	G	C	Biomarker=S252W;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123279612	123279612	-	GTCTCCTCCGACCACTGTGGA	Biomarker=S267_D273dup;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123276896	123276896	T	G	Biomarker=T341P;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123256219	123256219	C	A	Biomarker=V564F;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123256219	123256219	C	T	Biomarker=V564I;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123279564	123279564	A	T	Biomarker=W290R;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123279560	123279562	ATC	-	Biomarker=W290_I291delinsC;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123274794	123274794	T	C	Biomarker=Y375C;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr10	123274777	123274777	A	C	Biomarker=Y381D;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr4	1806089	1806089	G	T	Biomarker=G370C;Evidence_level=1|3A|4;Drug=Erdafitinib|AZD4547/BGJ398/Debio1347|AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=Bladder_Cancer|Bladder_Cancer|All_Solid_Tumors
chr4	1806119	1806119	G	A	Biomarker=G380R;Evidence_level=3A|4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib|AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=Bladder_Cancer|All_Solid_Tumors
chr4	1806153	1806153	C	A	Biomarker=A391E;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr4	1807863	1807863	A	G	Biomarker=D641G;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr4	1807862	1807862	G	A	Biomarker=D641N;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr4	1806104	1806104	G	T	Biomarker=G375C;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr4	1806126	1806126	G	A	Biomarker=G382D;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr4	1807363	1807363	A	G	Biomarker=I538V;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr4	1807889	1807889	A	G	Biomarker=K650E;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr4	1807890	1807890	A	T	Biomarker=K650M;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr4	1807891	1807891	G	C	Biomarker=K650N;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr4	1807889	1807889	A	C	Biomarker=K650Q;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr4	1807890	1807890	A	G	Biomarker=K650R;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr4	1807890	1807890	A	C	Biomarker=K650T;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr4	1807335	1807335	G	C	Biomarker=M528I;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr4	1807371	1807371	C	G	Biomarker=N540K;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr4	1807370	1807370	A	G	Biomarker=N540S;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr4	1803564	1803564	C	T	Biomarker=R248C;Evidence_level=4|1|3A;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib|Erdafitinib|AZD4547/BGJ398/Debio1347;Tumor_type=All_Solid_Tumors|Bladder_Cancer|Bladder_Cancer
chr4	1808029	1808029	C	G	Biomarker=R669G;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr4	1803568	1803568	C	G	Biomarker=S249C;Evidence_level=4|1|3A;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib|Erdafitinib|AZD4547/BGJ398/Debio1347;Tumor_type=All_Solid_Tumors|Bladder_Cancer|Bladder_Cancer
chr4	1806092	1806092	A	T	Biomarker=S371C;Evidence_level=4|3A;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib|AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors|Bladder_Cancer
chr4	1807494	1807494	G	A	Biomarker=V555M;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr4	1806099	1806099	A	G	Biomarker=Y373C;Evidence_level=4|1|3A;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib|Erdafitinib|AZD4547/BGJ398/Debio1347;Tumor_type=All_Solid_Tumors|Bladder_Cancer|Bladder_Cancer
chr4	1807881	1807881	A	G	Biomarker=Y647C;Evidence_level=4;Drug=AZD4547/BGJ398/Debio1347/Erdafitinib;Tumor_type=All_Solid_Tumors
chr13	28608087	28608087	C	T	Biomarker=A627T;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28592641	28592641	T	G	Biomarker=D835A;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28592640	28592640	A	C	Biomarker=D835E;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28592642	28592642	C	G	Biomarker=D835H;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28592642	28592642	C	T	Biomarker=D835N;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28592641	28592641	T	A	Biomarker=D835V;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28592642	28592642	C	A	Biomarker=D835Y;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28592640	28592642	ATC	-	Biomarker=D835del;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28592629	28592629	T	C	Biomarker=D839G;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28608287	28608288	TT	GG	Biomarker=F590G;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28608276	28608276	A	G	Biomarker=F594L;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28601361	28601361	A	G	Biomarker=F691L;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28592635	28592637	ATG	-	Biomarker=I836del;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28589780	28589780	A	C	Biomarker=I867S;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28602376	28602376	C	G	Biomarker=M664I;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28602342	28602342	T	C	Biomarker=N676D;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28602340	28602340	G	C	Biomarker=N676K;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28602341	28602341	T	C	Biomarker=N676S;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28592623	28592623	T	A	Biomarker=N841I;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28592644	28592644	C	T	Biomarker=R834Q;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28610137	28610139	TCC	GAG	Biomarker=S451E;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28610138	28610138	G	A	Biomarker=S451F;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28608320	28608320	A	G	Biomarker=V579A;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28608281	28608281	A	G	Biomarker=V592A;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28608281	28608281	A	C	Biomarker=V592G;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28608341	28608341	T	C	Biomarker=Y572C;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28608285	28608285	A	C	Biomarker=Y591D;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr13	28592620	28592620	T	C	Biomarker=Y842C;Evidence_level=1;Drug=Midostaurin+High_Dose_Chemotherapy;Tumor_type=Acute_Myeloid_Leukemia
chr11	534289	534289	-	ACCGCTACCAGG	Biomarker=A11_G12insPGSG;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534288	534288	-	CGTTTA	Biomarker=A11_G12insVN;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	533467	533467	C	T	Biomarker=A146T;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	533466	533466	G	A	Biomarker=A146V;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	533880	533880	G	C	Biomarker=A59G;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	533881	533881	C	T	Biomarker=A59T;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534241	534241	A	G	Biomarker=F28L;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534288	534288	C	G	Biomarker=G12A;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534289	534289	C	A	Biomarker=G12C;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534288	534288	C	T	Biomarker=G12D;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534287	534288	GC	AG	Biomarker=G12E;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534288	534289	GG	TT	Biomarker=G12F;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534288	534289	GG	CA	Biomarker=G12H;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534288	534289	GG	AT	Biomarker=G12I;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534287	534289	GGC	AAG	Biomarker=G12K;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534288	534289	GG	CT	Biomarker=G12L;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534287	534289	GGC	ATG	Biomarker=G12M;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534288	534289	GG	AA	Biomarker=G12N;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534287	534289	GGC	CAA	Biomarker=G12Q;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534289	534289	C	G	Biomarker=G12R;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534289	534289	C	T	Biomarker=G12S;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534288	534289	GG	AC	Biomarker=G12T;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534288	534288	C	A	Biomarker=G12V;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534287	534289	GGC	TGG	Biomarker=G12W;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534288	534289	GG	TA	Biomarker=G12Y;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534282	534282	-	CACCACCTG	Biomarker=G12_G13insGAG;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534285	534287	CCG	-	Biomarker=G12delG;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534286	534286	C	A	Biomarker=G13C;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534285	534285	C	T	Biomarker=G13D;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534286	534286	C	G	Biomarker=G13R;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534285	534285	C	A	Biomarker=G13V;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534277	534277	-	ACCTACACC	Biomarker=G15_K16insGVG;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	533552	533552	C	G	Biomarker=K117N;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	533553	533553	T	C	Biomarker=K117R;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534222	534222	G	C	Biomarker=P34R;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	534259	534259	G	T	Biomarker=Q22K;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	533873	533873	C	A	Biomarker=Q61H;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	533875	533875	G	T	Biomarker=Q61K;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	533874	533874	T	A	Biomarker=Q61L;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	533874	533874	T	C	Biomarker=Q61R;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr11	533883	533883	G	A	Biomarker=T58I;Evidence_level=3A;Drug=Tipifarnib;Tumor_type=Head_and_Neck_Squamous_Cell_Carcinoma
chr2	209113217	209113217	C	T	Biomarker=G97D;Evidence_level=1|3A;Drug=Ivosidenib|Ivosidenib;Tumor_type=Acute_Myeloid_Leukemia|Cholangiocarcinoma
chr2	209113208	209113209	CG	GC	Biomarker=R100A;Evidence_level=1|3A;Drug=Ivosidenib|Ivosidenib;Tumor_type=Acute_Myeloid_Leukemia|Cholangiocarcinoma
chr2	209113113	209113113	G	A	Biomarker=R132C;Evidence_level=1|3A;Drug=Ivosidenib|Ivosidenib;Tumor_type=Acute_Myeloid_Leukemia|Cholangiocarcinoma
chr2	209113113	209113113	G	C	Biomarker=R132G;Evidence_level=1|3A;Drug=Ivosidenib|Ivosidenib;Tumor_type=Acute_Myeloid_Leukemia|Cholangiocarcinoma
chr2	209113112	209113112	C	T	Biomarker=R132H;Evidence_level=1|3A;Drug=Ivosidenib|Ivosidenib;Tumor_type=Acute_Myeloid_Leukemia|Cholangiocarcinoma
chr2	209113111	209113112	GT	AA	Biomarker=R132Q;Evidence_level=1|3A;Drug=Ivosidenib|Ivosidenib;Tumor_type=Acute_Myeloid_Leukemia|Cholangiocarcinoma
chr2	209113113	209113113	G	T	Biomarker=R132S;Evidence_level=1|3A;Drug=Ivosidenib|Ivosidenib;Tumor_type=Acute_Myeloid_Leukemia|Cholangiocarcinoma
chr2	209110148	209110148	A	C	Biomarker=Y139D;Evidence_level=1|3A;Drug=Ivosidenib|Ivosidenib;Tumor_type=Acute_Myeloid_Leukemia|Cholangiocarcinoma
chr15	90631934	90631934	C	T	Biomarker=R140Q;Evidence_level=1;Drug=Enasidenib;Tumor_type=Acute_Myeloid_Leukemia
chr15	90631839	90631839	T	C	Biomarker=R172G;Evidence_level=1;Drug=Enasidenib;Tumor_type=Acute_Myeloid_Leukemia
chr15	90631838	90631838	C	T	Biomarker=R172K;Evidence_level=1;Drug=Enasidenib;Tumor_type=Acute_Myeloid_Leukemia
chr15	90631838	90631838	C	A	Biomarker=R172M;Evidence_level=1;Drug=Enasidenib;Tumor_type=Acute_Myeloid_Leukemia
chr15	90631837	90631837	C	G	Biomarker=R172S;Evidence_level=1;Drug=Enasidenib;Tumor_type=Acute_Myeloid_Leukemia
chr4	55599299	55599299	T	G	Biomarker=C809G;Evidence_level=1|2A|2A|2A|R2|2A|2A|1;Drug=Regorafenib|Sorafenib|Imatinib|Sorafenib/Sunitinib|Imatinib/Sunitinib|Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Melanoma|Thymic_Tumor|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55599321	55599321	A	C	Biomarker=D816A;Evidence_level=2A|R2|1|2A|2A|2A|2A|1;Drug=Imatinib|Imatinib/Sunitinib|Regorafenib|Sorafenib/Sunitinib|Sorafenib|Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Melanoma|Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55599322	55599322	C	G	Biomarker=D816E;Evidence_level=1|2A|2A|R2|2A|2A|2A|1;Drug=Regorafenib|Imatinib|Sorafenib|Imatinib/Sunitinib|Sorafenib/Sunitinib|Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Gastrointestinal_Stromal_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55599320	55599321	GA	TT	Biomarker=D816F;Evidence_level=2A|2A|R2|2A|1|2A|2A|1;Drug=Imatinib|Sorafenib/Sunitinib|Imatinib/Sunitinib|Sorafenib|Regorafenib|Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Melanoma|Thymic_Tumor|Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55599321	55599321	A	G	Biomarker=D816G;Evidence_level=1|R2|2A|2A|2A|2A|2A|1;Drug=Regorafenib|Imatinib/Sunitinib|Imatinib|Sorafenib/Sunitinib|Sorafenib|Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Melanoma|Thymic_Tumor|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55599320	55599320	G	C	Biomarker=D816H;Evidence_level=1|R2|2A|2A|2A|2A|2A|1;Drug=Regorafenib|Imatinib/Sunitinib|Imatinib|Sorafenib|Sorafenib/Sunitinib|Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55599320	55599320	G	A	Biomarker=D816N;Evidence_level=R2|2A|2A|1|2A|2A|2A|1;Drug=Imatinib/Sunitinib|Sorafenib|Imatinib|Regorafenib|Sorafenib/Sunitinib|Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55599321	55599321	A	T	Biomarker=D816V;Evidence_level=1|2A|2A|R2|2A|2A|2A|1;Drug=Regorafenib|Imatinib|Sorafenib/Sunitinib|Imatinib/Sunitinib|Sorafenib|Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Gastrointestinal_Stromal_Tumor|Melanoma|Thymic_Tumor|Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55599320	55599320	G	T	Biomarker=D816Y;Evidence_level=2A|1|R2|2A|2A|2A|2A|1;Drug=Sorafenib|Regorafenib|Imatinib/Sunitinib|Imatinib|Sorafenib/Sunitinib|Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Melanoma|Thymic_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55599333	55599333	A	C	Biomarker=D820A;Evidence_level=1|R2|2A|2A|2A|2A|2A|1;Drug=Regorafenib|Imatinib/Sunitinib|Sorafenib|Imatinib|Sorafenib/Sunitinib|Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Melanoma|Thymic_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55599334	55599334	T	G	Biomarker=D820E;Evidence_level=R2|1|2A|2A|2A|2A|2A|1;Drug=Imatinib/Sunitinib|Regorafenib|Sorafenib/Sunitinib|Sorafenib|Imatinib|Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Gastrointestinal_Stromal_Tumor|Melanoma|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55599333	55599333	A	G	Biomarker=D820G;Evidence_level=R2|2A|2A|2A|1|2A|2A|1;Drug=Imatinib/Sunitinib|Imatinib|Sorafenib/Sunitinib|Sorafenib|Regorafenib|Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Gastrointestinal_Stromal_Tumor|Melanoma|Thymic_Tumor|Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55599332	55599332	G	T	Biomarker=D820Y;Evidence_level=2A|1|2A|R2|2A|2A|2A|1;Drug=Sorafenib|Regorafenib|Imatinib|Imatinib/Sunitinib|Sorafenib/Sunitinib|Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55599338	55599338	A	C	Biomarker=N822H;Evidence_level=2A|R2|2A|2A|1|2A|2A|1;Drug=Sorafenib|Imatinib/Sunitinib|Sorafenib/Sunitinib|Imatinib|Regorafenib|Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55599339	55599339	A	T	Biomarker=N822I;Evidence_level=2A|2A|1|R2|2A|2A|2A|1;Drug=Sorafenib|Imatinib|Regorafenib|Imatinib/Sunitinib|Sorafenib/Sunitinib|Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Gastrointestinal_Stromal_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55599340	55599340	T	G	Biomarker=N822K;Evidence_level=2A|2A|R2|2A|1|2A|2A|1;Drug=Sorafenib|Imatinib|Imatinib/Sunitinib|Sorafenib/Sunitinib|Regorafenib|Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Gastrointestinal_Stromal_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55599338	55599338	A	T	Biomarker=N822Y;Evidence_level=1|R2|2A|2A|2A|2A|2A|1;Drug=Regorafenib|Imatinib/Sunitinib|Sorafenib/Sunitinib|Sorafenib|Imatinib|Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Gastrointestinal_Stromal_Tumor|Melanoma|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55592178	55592178	-	TGCCTA	Biomarker=A502_Y503dup;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55602664	55602664	G	C	Biomarker=A829P;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55589846	55589846	G	A	Biomarker=C443Y;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55589771	55589773	ACG	-	Biomarker=D419del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593649	55593649	A	C	Biomarker=D572A;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593667	55593669	ATG	-	Biomarker=D579del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55561788	55561788	G	A	Biomarker=D60N;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55592144	55592144	G	A	Biomarker=E490K;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593594	55593647	GAAGTACAGTGGAAGGTTGTTGAGGAGATAAATGGAAACAATTATGTTTACATA	-	Biomarker=E554_I571del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593594	55593608	GAAGTACAGTGGAAG	-	Biomarker=E554_K558del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593593	55593610	TGAAGTACAGTGGAAGGT	-	Biomarker=E554_V559del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593581	55593989	GAAACCCATGTATGAAGTACAGTGGAAGGTTGTTGAGGAGATAAATGGAAACAATTATGTTTACATAGACCCAACACAACTTCCTTATGATCACAAATGGGAGTTTCCCAGAAACAGGCTGAGTTTTGGTCAGTATGAAACAGGGGCTTTCCATGTCACCTTTTTGGGTACACATAACAGTGACTTTAAGGAACTCCAGTGGCTTCCTTTGTTTTGTTCCACCTGAAACAATGAGTTTTCTGTGAAATTGCGCCCCTTTTGATAGGTTTGCCATAGAGAACATCGTAGGAAAATGTCTCTGGACAACATTGTTTTTAATTCCTTTATTGATTTTGAAACTGCACAAATGGTCCTTCAATTCCACCACCAGCACCATCACCACTTACCTTGTTGTCTTCCTTCCTACAGG	-	Biomarker=K550_G592del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593585	55593605	CCCATGTATGAAGTACAGTGG	CTT	Biomarker=P551_W557delinsL;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593408	55593408	T	G	Biomarker=F522C;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55595599	55595599	C	T	Biomarker=H697Y;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593621	55593662	ATAAATGGAAACAATTATGTTTACATAGACCCAACACAACTT	-	Biomarker=I563_L576del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55594255	55594255	T	C	Biomarker=I653T;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55592202	55592202	A	T	Biomarker=K509I;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593580	55593606	AGAAACCCATGTATGAAGTACAGTGGA	-	Biomarker=K550_K558del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593583	55593597	AACCCATGTATGAAG	-	Biomarker=K550_V555delinsI;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593581	55593604	GAAACCCATGTATGAAGTACAGTG	-	Biomarker=K550_W557del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593608	55593608	G	C	Biomarker=K558N;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593605	55593619	GAAGGTTGTTGAGGA	-	Biomarker=K558_E562del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593606	55593611	AAGGTT	-	Biomarker=K558_V559del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593606	55593614	AAGGTTGTT	-	Biomarker=K558_V560del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593606	55593608	AAG	AACCCT	Biomarker=K558delinsNP;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55594221	55594221	A	G	Biomarker=K642E;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593661	55593661	T	C	Biomarker=L576P;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593660	55593662	CTT	-	Biomarker=L576del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593588	55593608	ATGTATGAAGTACAGTGGAAG	-	Biomarker=M552_K558del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593588	55593605	ATGTATGAAGTACAGTGG	-	Biomarker=M552_W557del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55592064	55592064	A	G	Biomarker=N463S;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55592190	55592190	A	T	Biomarker=N505I;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593624	55593668	AATGGAAACAATTATGTTTACATAGACCCAACACAACTTCCTTAT	-	Biomarker=N564_Y578del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55594262	55594262	T	G	Biomarker=N655K;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593583	55593594	AACCCATGTATG	-	Biomarker=P551_E554del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593585	55593590	CCCATG	-	Biomarker=P551_M552del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593584	55593598	ACCCATGTATGAAGT	-	Biomarker=P551_V555del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593651	55593671	CCAACACAACTTCCTTATGAT	-	Biomarker=P573_D579del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593662	55593670	TCCTTATGA	-	Biomarker=P577_D579del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593663	55593680	CCTTATGATCACAAATGG	CCTTATGAC	Biomarker=P577_W582delinsPYD;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55602692	55602692	C	T	Biomarker=P838L;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593600	55593608	CAGTGGAAG	-	Biomarker=Q556_K558del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55594197	55594197	C	T	Biomarker=R634W;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55592103	55592103	G	T	Biomarker=S476I;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55592176	55592176	-	TCTGCC	Biomarker=S501_A502dup;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55595636	55595637	CA	TT	Biomarker=S709F;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55589767	55589775	ACTTACGAC	ATC	Biomarker=T417_D419delinsI;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55589767	55589775	ACTTACGAC	AGGGGT	Biomarker=T417_D419delinsRG;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593654	55593698	ACACAACTTCCTTATGATCACAAATGGGAGTTTCCCAGAAACAGG	CTT	Biomarker=T574_R588delinsL;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55595519	55595519	C	T	Biomarker=T670I;Evidence_level=2A|2A|1|2A|1|R2|2A;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib|Sorafenib/Sunitinib|Regorafenib/Sunitinib|Imatinib|Imatinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Melanoma
chr4	55593431	55593431	G	A	Biomarker=V530I;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593597	55593662	GTACAGTGGAAGGTTGTTGAGGAGATAAATGGAAACAATTATGTTTACATAGACCCAACACAACTT	-	Biomarker=V555_L576del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593597	55593611	GTACAGTGGAAGGTT	-	Biomarker=V555_V559del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593610	55593610	T	C	Biomarker=V559A;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593609	55593610	GT	TG	Biomarker=V559C;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593610	55593610	T	A	Biomarker=V559D;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593610	55593610	T	G	Biomarker=V559G;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593609	55593609	G	A	Biomarker=V559I;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593609	55593629	GTTGTTGAGGAGATAAATGGA	-	Biomarker=V559_G565del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593609	55593614	GTTGTT	-	Biomarker=V559_V560del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593609	55593611	GTT	-	Biomarker=V559del|V560del;Evidence_level=2A|2A|1|2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib|Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593613	55593613	T	A	Biomarker=V560D;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593613	55593614	TT	AG	Biomarker=V560E;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593613	55593613	T	G	Biomarker=V560G;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593638	55593661	TGTTTACATAGACCCAACACAACT	-	Biomarker=V569_L576del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55594258	55594258	T	C	Biomarker=V654A;Evidence_level=2A|2A|1|2A|1|R2|2A;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib|Sorafenib/Sunitinib|Regorafenib/Sunitinib|Imatinib|Imatinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Melanoma
chr4	55602733	55602733	G	A	Biomarker=V852I;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593605	55593605	G	T	Biomarker=W557C;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593603	55593603	T	G	Biomarker=W557G;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593603	55593603	T	A	Biomarker=W557R;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593601	55593606	AGTGGA	-	Biomarker=W557_K558del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593605	55593610	GAAGGT	-	Biomarker=W557_V559delinsC;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593603	55593614	TGGAAGGTTGTT	-	Biomarker=W557_V560del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55589770	55589775	TACGAC	-	Biomarker=Y418_D419del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593591	55593591	T	A	Biomarker=Y553N;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593590	55593607	GTATGAAGTACAGTGGAA	-	Biomarker=Y553_K558del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593590	55593601	GTATGAAGTACA	-	Biomarker=Y553_Q556del;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593636	55593662	TATGTTTACATAGACCCAACACAACTT	GTAAAC	Biomarker=Y568_L576delinsVN;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593642	55593642	T	C	Biomarker=Y570H;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55593667	55593667	A	G	Biomarker=Y578C;Evidence_level=2A|2A|1;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor
chr4	55599341	55599341	T	G	Biomarker=Y823D;Evidence_level=2A|2A|1|1|2A|2A|2A|R2;Drug=Sorafenib/Sunitinib|Imatinib|Imatinib/Regorafenib/Sunitinib|Regorafenib|Sorafenib/Sunitinib|Imatinib|Sorafenib|Imatinib/Sunitinib;Tumor_type=Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor
chr4	55599260	55599260	A	G	Biomarker=R796G;Evidence_level=1|2A|2A|R2|2A;Drug=Regorafenib|Sorafenib/Sunitinib|Imatinib|Imatinib/Sunitinib|Sorafenib;Tumor_type=Gastrointestinal_Stromal_Tumor|Thymic_Tumor|Melanoma|Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor
chr12	25398285	25398285	C	A	Biomarker=G12C;Evidence_level=3A|3A|4|R1;Drug=AMG_510|Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Non_Small_Cell_Lung_Cancer|Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398281	25398281	-	CACCTG	Biomarker=A11_G12insGA;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25378562	25378562	C	T	Biomarker=A146T;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25378561	25378561	G	A	Biomarker=A146V;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398266	25398266	G	T	Biomarker=A18D;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25380282	25380282	G	C	Biomarker=A59G;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25378643	25378643	C	T	Biomarker=D119N;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398220	25398220	A	C	Biomarker=D33E;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398226	25398226	T	G	Biomarker=E31D;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25380274	25380274	C	T	Biomarker=E62K;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25380271	25380271	C	T	Biomarker=E63K;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25368479	25368479	A	G	Biomarker=F156L;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398237	25398237	A	G	Biomarker=F28L;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398287	25398287	-	CTC	Biomarker=G10dup;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398284	25398284	C	G	Biomarker=G12A;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398284	25398284	C	T	Biomarker=G12D;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398284	25398285	GG	TT	Biomarker=G12F;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398285	25398285	C	G	Biomarker=G12R;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398285	25398285	C	T	Biomarker=G12S;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398284	25398284	C	A	Biomarker=G12V;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398282	25398282	C	A	Biomarker=G13C;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398281	25398281	C	T	Biomarker=G13D;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25380280	25380280	C	G	Biomarker=G60R;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25378647	25378647	T	G	Biomarker=K117N;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25378559	25378559	T	C	Biomarker=K147E;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398304	25398304	T	G	Biomarker=K5N;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398262	25398262	C	A	Biomarker=L19F;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398218	25398218	G	A	Biomarker=P34L;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398218	25398218	G	C	Biomarker=P34R;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398255	25398255	G	C	Biomarker=Q22E;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398255	25398255	G	T	Biomarker=Q22K;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398254	25398254	T	C	Biomarker=Q22R;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25380275	25380275	T	A	Biomarker=Q61H;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25380276	25380276	T	A	Biomarker=Q61L;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25380276	25380276	T	C	Biomarker=Q61R;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25378553	25378553	T	C	Biomarker=R149G;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25380264	25380264	C	T	Biomarker=S65N;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25380285	25380285	G	A	Biomarker=T58I;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25380238	25380238	T	G	Biomarker=T74P;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398279	25398279	C	T	Biomarker=V14I;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25398224	25398224	T	G	Biomarker=Y32S;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25380267	25380268	TA	GC	Biomarker=Y64A;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr12	25380247	25380247	A	G	Biomarker=Y71H;Evidence_level=3A|4|R1;Drug=Cobimetinib|Binimetinib/Cobimetinib/Trametinib|Cetuximab/Panitumumab;Tumor_type=Histiocytosis|All_Solid_Tumors|Colorectal_Cancer
chr15	66729153	66729153	T	A	Biomarker=C121S;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727483	66727483	G	A	Biomarker=D67N;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729096	66729101	GAGATC	-	Biomarker=E102_I103del;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729222	66729222	G	A	Biomarker=E144K;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66774131	66774131	G	A	Biomarker=E203K;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727435	66727458	GAGGCCTTTCTTACCCAGAAGCAG	-	Biomarker=E51_Q58del;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729177	66729177	T	C	Biomarker=F129L;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727442	66727442	T	G	Biomarker=F53C;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727441	66727441	T	C	Biomarker=F53L;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727442	66727442	T	C	Biomarker=F53S;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727441	66727458	TTTCTTACCCAGAAGCAG	-	Biomarker=F53_Q58del;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729175	66729175	G	A	Biomarker=G128D;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729175	66729175	G	T	Biomarker=G128V;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729148	66729148	A	C	Biomarker=H119P;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729100	66729100	T	A	Biomarker=I103N;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729099	66729104	ATCAAA	-	Biomarker=I103_K104del;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729123	66729124	AT	GC	Biomarker=I111A;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729124	66729124	T	A	Biomarker=I111N;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729123	66729124	AT	CC	Biomarker=I111P;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729124	66729125	TC	GG	Biomarker=I111R;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66774135	66774135	T	C	Biomarker=I204T;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729086	66729103	AATTCATCTGGAGATCAA	-	Biomarker=I99_K104del;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727453	66727453	A	G	Biomarker=K57E;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727455	66727455	G	C	Biomarker=K57N;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727454	66727454	A	C	Biomarker=K57T;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727457	66727459	AGA	-	Biomarker=K59del;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729136	66729136	T	C	Biomarker=L115P;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729136	66729136	T	G	Biomarker=L115R;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66737006	66737006	C	A	Biomarker=L177M;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66737006	66737006	C	G	Biomarker=L177V;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727394	66727394	T	C	Biomarker=L37P;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729084	66729101	CTAATTCATCTGGAGATC	-	Biomarker=L98_I103del;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729085	66729102	TAATTCATCTGGAGATCA	-	Biomarker=L98_K104delinsQ;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729115	66729129	GGAACCAGATCATAA	-	Biomarker=N109_R113del;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729105	66729113	CCCGCAATC	-	Biomarker=P105_I107del;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729105	66729113	CCCGCAATC	AGC	Biomarker=P105_I107delinsS;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729163	66729163	C	T	Biomarker=P124L;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729163	66729163	C	A	Biomarker=P124Q;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729162	66729162	C	T	Biomarker=P124S;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66779587	66779587	C	A	Biomarker=P306H;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727451	66727451	A	C	Biomarker=Q56P;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727450	66727464	CAGAAGCAGAAGGTG	-	Biomarker=Q56_V60del;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727456	66727470	CAGAAGGTGGGAGAA	-	Biomarker=Q58_E62del;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727424	66727424	G	A	Biomarker=R47Q;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727430	66727430	G	T	Biomarker=R49L;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729159	66729159	T	A	Biomarker=S123T;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66774176	66774177	TC	GA	Biomarker=S218D;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66774188	66774189	TC	GA	Biomarker=S222D;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727367	66727367	C	T	Biomarker=T28I;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66735639	66735639	G	A	Biomarker=V154I;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66774156	66774156	T	A	Biomarker=V211D;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727463	66727463	T	A	Biomarker=V60E;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66727462	66727462	G	A	Biomarker=V60M;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr15	66729181	66729181	A	G	Biomarker=Y130C;Evidence_level=3A|3A|3A|3A;Drug=Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib|Cobimetinib/Trametinib;Tumor_type=Melanoma|Histiocytosis|Non_Small_Cell_Lung_Cancer|Low_Grade_Serous_Ovarian_Cancer
chr19	4110584	4110584	A	T	Biomarker=C125S;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr19	4101103	4101103	C	T	Biomarker=E207K;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr19	4117550	4117550	A	C	Biomarker=F57C;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr19	4117551	4117551	A	G	Biomarker=F57L;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr19	4117551	4117551	A	C	Biomarker=F57V;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr19	4117584	4117584	G	A	Biomarker=L46F;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr19	4110581	4110581	T	C	Biomarker=N126D;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr19	4117541	4117541	T	G	Biomarker=Q60P;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr19	4117617	4117617	C	T	Biomarker=V35M;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr19	4110557	4110557	A	G	Biomarker=Y134H;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr7	116423407	116423407	G	A	Biomarker=D1228N;Evidence_level=R2;Drug=Cabozantinib/Capmatinib/Crizotinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr7	116423413	116423413	T	C	Biomarker=Y1230H;Evidence_level=R2;Drug=Capmatinib/Crizotinib;Tumor_type=Non_Small_Cell_Lung_Cancer
chr1	11187857	11187857	C	T	Biomarker=E2014K;Evidence_level=3A|4;Drug=Everolimus|Everolimus/Temsirolimus;Tumor_type=Bladder_Cancer|All_Solid_Tumors
chr1	11174420	11174420	C	T	Biomarker=E2419K;Evidence_level=3A|4;Drug=Everolimus|Everolimus/Temsirolimus;Tumor_type=Bladder_Cancer|All_Solid_Tumors
chr1	11217299	11217299	A	G	Biomarker=L1460P;Evidence_level=3A|4;Drug=Temsirolimus|Everolimus/Temsirolimus;Tumor_type=Renal_Cell_Carcinoma|All_Solid_Tumors
chr1	11184592	11184592	G	C	Biomarker=L2209V;Evidence_level=3A|4;Drug=Temsirolimus|Everolimus/Temsirolimus;Tumor_type=Renal_Cell_Carcinoma|All_Solid_Tumors
chr1	11174395	11174395	A	T	Biomarker=L2427Q;Evidence_level=3A|4;Drug=Temsirolimus|Everolimus/Temsirolimus;Tumor_type=Renal_Cell_Carcinoma|All_Solid_Tumors
chr1	11227546	11227546	C	T	Biomarker=A1428T;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11217303	11217303	C	G	Biomarker=A1459P;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11210198	11210198	C	T	Biomarker=A1519T;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11184589	11184589	C	G	Biomarker=A2210P;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11182170	11182170	C	A	Biomarker=A2226S;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11217230	11217230	C	A	Biomarker=C1483F;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11217231	11217231	A	G	Biomarker=C1483R;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11217229	11217229	G	C	Biomarker=C1483W;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11217230	11217230	C	T	Biomarker=C1483Y;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11168338	11168338	C	G	Biomarker=D2512H;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11190804	11190804	C	T	Biomarker=E1799K;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11181374	11181374	C	T	Biomarker=E2288K;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11189847	11189847	A	T	Biomarker=F1888I;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11189847	11189847	A	G	Biomarker=F1888L;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11189847	11189847	A	C	Biomarker=F1888V;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11188177	11188177	T	A	Biomarker=I1973F;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11169377	11169377	T	A	Biomarker=I2500F;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11169375	11169375	A	C	Biomarker=I2500M;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11217322	11217322	T	G	Biomarker=K1452N;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11227530	11227530	A	G	Biomarker=L1433S;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11186691	11186691	A	T	Biomarker=L2172M;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11184570	11184570	A	G	Biomarker=L2216P;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11184559	11184559	G	A	Biomarker=L2220F;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11182158	11182158	A	C	Biomarker=L2230V;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11174395	11174395	A	G	Biomarker=L2427P;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11174395	11174395	A	C	Biomarker=L2427R;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11174383	11174383	A	G	Biomarker=L2431P;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11177096	11177096	C	G	Biomarker=M2327I;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11181419	11181419	G	A	Biomarker=P2273S;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11182179	11182179	G	T	Biomarker=Q2223K;Evidence_level=4|3A;Drug=Everolimus/Temsirolimus|Everolimus;Tumor_type=All_Solid_Tumors|Renal_Cell_Carcinoma
chr1	11184568	11184568	G	A	Biomarker=R2217W;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11169361	11169361	C	G	Biomarker=R2505P;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11184573	11184573	G	A	Biomarker=S2215F;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11184574	11184574	A	G	Biomarker=S2215P;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11184574	11184574	A	T	Biomarker=S2215T;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11184573	11184573	G	T	Biomarker=S2215Y;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11182154	11182154	G	C	Biomarker=S2231W;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11188164	11188164	G	A	Biomarker=T1977I;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11188164	11188164	G	T	Biomarker=T1977K;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11188164	11188164	G	C	Biomarker=T1977R;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11182151	11182151	G	A	Biomarker=T2232I;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11188078	11188078	C	A	Biomarker=V2006F;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11188078	11188078	C	T	Biomarker=V2006I;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11188078	11188078	C	G	Biomarker=V2006L;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11217312	11217312	A	T	Biomarker=W1456R;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr1	11217290	11217290	T	G	Biomarker=Y1463S;Evidence_level=4;Drug=Everolimus/Temsirolimus;Tumor_type=All_Solid_Tumors
chr17	29576094	29576094	A	G	Biomarker=E1356G;Evidence_level=4;Drug=Cobimetinib/Trametinib;Tumor_type=All_Solid_Tumors
chr17	29552152	29552152	G	A	Biomarker=G629R;Evidence_level=4;Drug=Cobimetinib/Trametinib;Tumor_type=All_Solid_Tumors
chr17	29562967	29562967	T	G	Biomarker=L1301R;Evidence_level=4;Drug=Cobimetinib/Trametinib;Tumor_type=All_Solid_Tumors
chr17	29486092	29486092	T	G	Biomarker=L90R;Evidence_level=4;Drug=Cobimetinib/Trametinib;Tumor_type=All_Solid_Tumors
chr17	29560133	29560133	C	G	Biomarker=R1204G;Evidence_level=4;Drug=Cobimetinib/Trametinib;Tumor_type=All_Solid_Tumors
chr17	29560133	29560133	C	T	Biomarker=R1204W;Evidence_level=4;Drug=Cobimetinib/Trametinib;Tumor_type=All_Solid_Tumors
chr17	29562747	29562747	G	C	Biomarker=R1276P;Evidence_level=4;Drug=Cobimetinib/Trametinib;Tumor_type=All_Solid_Tumors
chr17	29562747	29562747	G	A	Biomarker=R1276Q;Evidence_level=4;Drug=Cobimetinib/Trametinib;Tumor_type=All_Solid_Tumors
chr17	29677227	29677227	C	T	Biomarker=R2450*;Evidence_level=4;Drug=Cobimetinib/Trametinib;Tumor_type=All_Solid_Tumors
chr17	29563036	29563036	C	A	Biomarker=T1324N;Evidence_level=4;Drug=Cobimetinib/Trametinib;Tumor_type=All_Solid_Tumors
chr17	29541542	29541542	A	G	Biomarker=Y489C;Evidence_level=4;Drug=Cobimetinib/Trametinib;Tumor_type=All_Solid_Tumors
chr1	115258748	115258748	C	A	Biomarker=G12C;Evidence_level=3A|3A|3A|R1;Drug=Binimetinib/Binimetinib+Ribociclib|Iodine_I_131_6_Beta_Iodomethyl_19_Norcholesterol+Selumetinib|Cobimetinib|Cetuximab/Panitumumab;Tumor_type=Melanoma|Thyroid_Cancer|Histiocytosis|Colorectal_Cancer
chr1	115258747	115258747	C	T	Biomarker=G12D;Evidence_level=3A|3A|3A|R1;Drug=Binimetinib/Binimetinib+Ribociclib|Iodine_I_131_6_Beta_Iodomethyl_19_Norcholesterol+Selumetinib|Cobimetinib|Cetuximab/Panitumumab;Tumor_type=Melanoma|Thyroid_Cancer|Histiocytosis|Colorectal_Cancer
chr1	115258748	115258748	C	G	Biomarker=G12R;Evidence_level=3A|3A|3A|R1;Drug=Binimetinib/Binimetinib+Ribociclib|Iodine_I_131_6_Beta_Iodomethyl_19_Norcholesterol+Selumetinib|Cobimetinib|Cetuximab/Panitumumab;Tumor_type=Melanoma|Thyroid_Cancer|Histiocytosis|Colorectal_Cancer
chr1	115258747	115258747	C	A	Biomarker=G12V;Evidence_level=3A|3A|3A|R1;Drug=Binimetinib/Binimetinib+Ribociclib|Iodine_I_131_6_Beta_Iodomethyl_19_Norcholesterol+Selumetinib|Cobimetinib|Cetuximab/Panitumumab;Tumor_type=Melanoma|Thyroid_Cancer|Histiocytosis|Colorectal_Cancer
chr1	115258744	115258744	C	T	Biomarker=G13D;Evidence_level=3A|3A|3A|R1;Drug=Binimetinib/Binimetinib+Ribociclib|Iodine_I_131_6_Beta_Iodomethyl_19_Norcholesterol+Selumetinib|Cobimetinib|Cetuximab/Panitumumab;Tumor_type=Melanoma|Thyroid_Cancer|Histiocytosis|Colorectal_Cancer
chr1	115258744	115258744	C	A	Biomarker=G13V;Evidence_level=3A|3A|3A|R1;Drug=Binimetinib/Binimetinib+Ribociclib|Iodine_I_131_6_Beta_Iodomethyl_19_Norcholesterol+Selumetinib|Cobimetinib|Cetuximab/Panitumumab;Tumor_type=Melanoma|Thyroid_Cancer|Histiocytosis|Colorectal_Cancer
chr1	115256532	115256532	C	T	Biomarker=G60E;Evidence_level=3A|3A|3A|R1;Drug=Binimetinib/Binimetinib+Ribociclib|Iodine_I_131_6_Beta_Iodomethyl_19_Norcholesterol+Selumetinib|Cobimetinib|Cetuximab/Panitumumab;Tumor_type=Melanoma|Thyroid_Cancer|Histiocytosis|Colorectal_Cancer
chr1	115256528	115256528	T	A	Biomarker=Q61H;Evidence_level=3A|3A|3A|R1;Drug=Binimetinib/Binimetinib+Ribociclib|Iodine_I_131_6_Beta_Iodomethyl_19_Norcholesterol+Selumetinib|Cobimetinib|Cetuximab/Panitumumab;Tumor_type=Melanoma|Thyroid_Cancer|Histiocytosis|Colorectal_Cancer
chr1	115256530	115256530	G	T	Biomarker=Q61K;Evidence_level=3A|3A|3A|R1;Drug=Binimetinib/Binimetinib+Ribociclib|Iodine_I_131_6_Beta_Iodomethyl_19_Norcholesterol+Selumetinib|Cobimetinib|Cetuximab/Panitumumab;Tumor_type=Melanoma|Thyroid_Cancer|Histiocytosis|Colorectal_Cancer
chr1	115256529	115256529	T	A	Biomarker=Q61L;Evidence_level=3A|3A|3A|R1;Drug=Binimetinib/Binimetinib+Ribociclib|Iodine_I_131_6_Beta_Iodomethyl_19_Norcholesterol+Selumetinib|Cobimetinib|Cetuximab/Panitumumab;Tumor_type=Melanoma|Thyroid_Cancer|Histiocytosis|Colorectal_Cancer
chr1	115256529	115256529	T	C	Biomarker=Q61R;Evidence_level=3A|3A|3A|R1;Drug=Binimetinib/Binimetinib+Ribociclib|Iodine_I_131_6_Beta_Iodomethyl_19_Norcholesterol+Selumetinib|Cobimetinib|Cetuximab/Panitumumab;Tumor_type=Melanoma|Thyroid_Cancer|Histiocytosis|Colorectal_Cancer
chr1	115256562	115256562	G	A	Biomarker=T50I;Evidence_level=3A|3A|3A|R1;Drug=Binimetinib/Binimetinib+Ribociclib|Iodine_I_131_6_Beta_Iodomethyl_19_Norcholesterol+Selumetinib|Cobimetinib|Cetuximab/Panitumumab;Tumor_type=Melanoma|Thyroid_Cancer|Histiocytosis|Colorectal_Cancer
chr1	115256538	115256538	G	A	Biomarker=T58I;Evidence_level=3A|3A|3A|R1;Drug=Binimetinib/Binimetinib+Ribociclib|Iodine_I_131_6_Beta_Iodomethyl_19_Norcholesterol+Selumetinib|Cobimetinib|Cetuximab/Panitumumab;Tumor_type=Melanoma|Thyroid_Cancer|Histiocytosis|Colorectal_Cancer
chr1	156846342	156846342	G	A	Biomarker=G595R;Evidence_level=R2;Drug=Larotrectinib;Tumor_type=All_Solid_Tumors
chr15	88476265	88476265	C	T	Biomarker=G623R;Evidence_level=R2;Drug=Larotrectinib;Tumor_type=All_Solid_Tumors
chr4	55152093	55152093	A	T	Biomarker=D842V;Evidence_level=R1|2A|2A;Drug=Imatinib|Dasatinib|Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor|Gastrointestinal_Stromal_Tumor
chr4	55144068	55144068	G	A	Biomarker=A633T;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55138672	55138672	-	CATGATCGAGTGGATGAT	Biomarker=C450_K451insMIEWMI;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55139705	55139743	TGTAATAATGAAACTTCCTGGACTATTTTGGCCAACAAT	-	Biomarker=C456_N468del;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55139705	55139782	TGTAATAATGAAACTTCCTGGACTATTTTGGCCAACAATGTCTCAAACATCATCACGGAGATCCACTCCCGAGACAGG	-	Biomarker=C456_R481del;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55141056	55141056	G	A	Biomarker=D568N;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55152092	55152093	GA	AT	Biomarker=D842I;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55152092	55152092	G	T	Biomarker=D842Y;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55152092	55152103	GACATCATGCAT	-	Biomarker=D842_H845del;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55152092	55152097	GACATC	ATCATG	Biomarker=D842_I843delinsIM;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55152092	55152100	GACATCATG	-	Biomarker=D842_M844del;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55152104	55152104	G	T	Biomarker=D846Y;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55133627	55133723	GGTACATTCCGCTTTCTAAAATGTCAGTTGTCCATGCTGCTCGGGATCCATATGTGGTAATCATTATTTAATGGAAACTCTTCCCTGTACAGAGAAA	-	Biomarker=E311_K312del;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55152126	55152126	G	A	Biomarker=G853D;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55144121	55144121	C	A	Biomarker=H650Q;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55152101	55152101	C	T	Biomarker=H845Y;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55152101	55152112	CATGATTCGAAC	CCT	Biomarker=H845_N848delinsP;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55152095	55152106	ATCATGCATGAT	-	Biomarker=I843_D846del;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55152094	55152096	CAT	-	Biomarker=I843del;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55144148	55144148	C	G	Biomarker=N659K;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55144147	55144148	AC	GG	Biomarker=N659R;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55144147	55144147	A	G	Biomarker=N659S;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55152112	55152112	C	G	Biomarker=N848K;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55141083	55141083	C	T	Biomarker=P577S;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55141090	55141090	A	G	Biomarker=Q579R;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55141030	55141030	-	GAGGGA	Biomarker=R560_V561insER;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55146568	55146568	A	G	Biomarker=R748G;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55152090	55152090	G	A	Biomarker=R841K;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55141052	55141066	CCCAGATGGACATGA	-	Biomarker=S566_E571delinsR;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55141105	55141105	C	T	Biomarker=S584L;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55144547	55144547	C	T	Biomarker=T674I;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55139745	55139745	T	C	Biomarker=V469A;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55140746	55140746	T	A	Biomarker=V536E;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55140769	55140769	-	TCGCAGTACTTGTACTTCTTGTAATCGTAATCATCAGCCTTA	Biomarker=V544_L545insAVLVLLVIVIISLI;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55141036	55141036	T	C	Biomarker=V561A;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55141036	55141036	T	A	Biomarker=V561D;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55141037	55141037	-	GAGAGG	Biomarker=V561_I562insER;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55144144	55144144	T	C	Biomarker=V658A;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55141029	55141034	TGGAGG	-	Biomarker=W559_R560del;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55133559	55133559	A	G	Biomarker=Y288C;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55136801	55139704	TATCGAAGCAAATTAAAGCTGATCCGTGCTAAGGAAGAAGACAGTGGCCATTATACTATTGTAGCTCAAAATGAAGATGCTGTGAAGAGCTATACTTTTGAACTGTTAACTCAAGGTATGTAAAGGGAGTATAAAGATAATGCTAGCTCTGTAGATGAGTGTCTTCCAAGGAAAGCCTGGCACTTTTCTCCCCGGTCATGGAAGAAAAGCAGCACTTAGGGGAGAAGCAGTGTCTGCATATGTCACATATCGGGAATACCTCTGCTGGACTCATGAATTCAGGTATTTCTGGGAGGTTCTGGGTTACTCTAGAGTAGGCGAGGAATCCCTAGGCTCCACCAGCTAGCTTTATTTTTGTAGAGATGGAGTCTTGCCATGTTGCTCAGGCTGGTCTCCTGGGTTCAAGCTATCTTCCCACCTTGGCCTCTCAAAGTACTGGGATTACAGGTGTGAGCCACTGCACCTGGCCTCCACCAGCTTACTTAGCACCTGCTTCTCAATCTGAGAAGAGAGAAGCAGATGACCTTAGATTGTTCTGGAGAGTTTTGCTACAAGTTTTCCTTATAGACATTGTACAGTGGTCCTTACCAGAAGGGAGTGCCCAAGTCTGTTTACATTCAGGCTCAGCACCTATCCAGAGTCCCAGCCATGAGCCAGGTGCTGTCTGAGGTGCGCTCATGTGATCCTCACAGTAAAACCTGTGATACAAGCAACACCGTATATCTAATTTATTTGACCACAGATTTAGAAAAGAATCTTTAAAACCTAATAACATACCACAGATGCATTTTGGTAAATGCTGCTTTAGATTATACTTTAGCTGAATCCATTAGTTGAATCCTAAGCTATAATATAATTTTAAGAACCTCCTTGCCTTTCAAGCCAAATAACCAAGGGACTTTCTCTCTCTCTTTCCCTCCCTCCCTTCCTTCCTTCCTTCCTTCTTCTCTCCCTCCCTTGTTATCTCTTTTCCTTTCCTTTCTCTCCTTCCTTCCCTCTTCCCTTTTTCCTTTCTCTCCTTCCTTCCTTCCTTGCTTCCTTCTTCCCTCCCTCCTTTGTTCTCTCTTTTCCTTTCCTTTCTCTTTTTCTTTCCTTCCTTCCTTCCTCACTCACTCTTTTCTTTTCCTTTCTCTCCTTCCTTCCTTCCTTCCTCCCTCCCTCACTCTCTCTTTTCTTTGCCTTTCTCTCCTTCCTTCCTTCCTTTTCCTCCCTCCCTCCCTCCCTTGTTCTCCCTTTTCCTTCCTTCCTTCTTTCCTTTCTTCCTTCCTTCCCTCTTCCCTCACTCTCTCTTTTCCTTTCTCTCCTTCCTTCCTTCCTTCATTCTCCCCTCCCCTCCCCCCTCCCCTCCCCCTCCCCTCCCCCCTCCCCCCCTCCCCTCCCCTTCCCTTCCCTTCCCATTTTTCTTCTCACCATGTTGCCCAGGCTTGCCTCAAACTCCTGGGCTCAAGTGTTTCTCTTCCACCTCAGCCTCCCAAGTAGCTGGGGCTACATGTGTGAGGCATCACAACCATGGACTTTTCACTTTCTTCACTCCAGGTTAAAAACATCACAGGGATAAATCTCAAAACACCAAAACTGTGAAAATGCTGCTAACCATGTGGGTCTGTCTAAACTGGAGTGTTACTTGTACAACTGGTTTCAGCCCCTCCGGAGTGTTTTGAATGCCATGTAGATGAGTTGTGAACTCATATTCCACTTTGTAGTCTCATATGTTCTGGGACACGAGCTATTCCATTCTGACTTCTTTCTGCCTCTTGCAGTTCCTTCATCCATTCTGGACTTGGTCGATGATCACCATGGCTCAACTGGGGGACAGACGGTGAGGTGCACAGCTGAAGGCACGCCGCTTCCTGATATTGAGTGGATGATATGCAAAGATATTAAGAAGTATGGAAAACAGATGTGTCTTCTTCTTTCGTGGTCAGAATATTTCTCCCTTGACACAAATGATGTCAAATACATTTTACTTATTGACTATAAGATAGGGTTTTGGGTGTGATAGCTTCAGGGTGTGTATCTTTTGTCATGAATAGCTGTGAGAAGAAGGTCCAGGGCTCTCATTAGACCTTCAAAATGTCTCCAATCTAAAAACAAGAGTGAATTTTAAGAACCACTGTTCTAAGAAGATTTTTACTACCCTGGCTCACATATCTTATTTGGTGAACTTTGTTTGGTAGTCGGACTGCATGTAAACATAAATGTGACTGCTTAGTCCCTTATCTGCCCACCTGCTGTTTGGTGGGTTAATTCGCCATTCCCTCCTCCCTCCCCCGAGTCCTCAGCCTTCTTAAATGGGCACATGAGCAATGTGTTTACACTTCATCCATGGTAACTGGTTGTGTTCAGAAGCCTCAGTTGTTTCTTCCTCTAGACAGAGACTCCTCATCTTAACTTCTAGGGCTAAGAACAGACTTGGATGTTGACTGGGGTTTCTAGTAGATTCCAGTGTGGAGCAGGATTCTAGGTCTTATAACTCAATCTGAGGATCATCGCAACCCTAGTGACACCCTAGGGGCTCTTCCCAGTGTGAGTGTTGAGAAGGGAGGGCTCCAGGCCTTTTTGAAGGGGTGGGAGATTGAGATCATTAAATATGGTTGAAGTTGAACTGTTCAGTTTGCTCATAGGTTCAAGATTGGGGAATGGTAGTCATATTTTATTAAACTTGATTATCTCTGCCTGCTATGTAAACACTTAGCTTTCAGTTGTTCATGTGTGAGTTATTCCCTCTTCAGCACATGCAGACAAGTTTTAATGTTCATCTGCATGTAAAATAAATCAGTGTGTATTGCCCCGAAATGCAGACAAGGTCCCAACTCCTTGCCATCTTAGAGTGTTCCCGTGGCTCCACTCATTGCCATGACTCTCAGGAATTGGCCCTATACTTAGGCCCTTTTTCTCTCTAGA	-	Biomarker=Y375_K455del;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55141018	55141018	A	G	Biomarker=Y555C;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55152114	55152114	A	G	Biomarker=Y849C;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr4	55152114	55152114	A	C	Biomarker=Y849S;Evidence_level=2A;Drug=Imatinib;Tumor_type=Gastrointestinal_Stromal_Tumor
chr3	178952142	178952142	C	T	Biomarker=A1066V;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178922363	178922363	T	C	Biomarker=C378R;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178927980	178927980	T	C	Biomarker=C420R;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178937422	178937422	T	C	Biomarker=C604R;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178947827	178947827	G	T	Biomarker=C901F;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178952030	178952030	G	T	Biomarker=D1029Y;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178921567	178921567	A	G	Biomarker=D350G;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178921566	178921566	G	A	Biomarker=D350N;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178936103	178936103	G	A	Biomarker=D549N;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178948044	178948044	A	G	Biomarker=D939G;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178952054	178952054	G	A	Biomarker=E1037K;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916922	178916930	ACCAGTAGG	-	Biomarker=E103_G106delinsD;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916920	178916925	GAACCA	-	Biomarker=E103_P104delEP;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916940	178916948	AGAAAAGAT	-	Biomarker=E109_I112delinsD;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916941	178916941	G	A	Biomarker=E110K;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916938	178916940	GAA	-	Biomarker=E110del;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178919167	178919167	G	A	Biomarker=E218K;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178922324	178922324	G	A	Biomarker=E365K;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916728	178916728	G	A	Biomarker=E39K;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178928080	178928080	A	C	Biomarker=E453A;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178928079	178928079	G	A	Biomarker=E453K;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178928079	178928079	G	C	Biomarker=E453Q;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178936082	178936082	G	A	Biomarker=E542K;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178936082	178936082	G	C	Biomarker=E542Q;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178936083	178936083	A	T	Biomarker=E542V;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178936092	178936092	A	C	Biomarker=E545A;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178936093	178936093	G	C	Biomarker=E545D;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178936092	178936092	A	G	Biomarker=E545G;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178936091	178936091	G	A	Biomarker=E545K;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178936091	178936091	G	C	Biomarker=E545Q;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178937054	178937054	G	A	Biomarker=E579K;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178937410	178937410	G	A	Biomarker=E600K;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916845	178916845	G	A	Biomarker=E78K;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178948136	178948136	G	A	Biomarker=E970K;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178951964	178951964	G	C	Biomarker=G1007R;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178952090	178952090	G	C	Biomarker=G1049R;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916930	178916930	G	A	Biomarker=G106D;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916929	178916929	G	C	Biomarker=G106R;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916930	178916930	G	T	Biomarker=G106V;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916929	178916937	GGCAACCGT	-	Biomarker=G106_R108del|G106_R108delGNR;Evidence_level=1|3A|1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant|Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer|Breast_Cancer|Breast_Cancer
chr3	178917478	178917478	G	A	Biomarker=G118D;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178922321	178922321	G	A	Biomarker=G364R;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178928073	178928073	G	A	Biomarker=G451R;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178947865	178947865	G	A	Biomarker=G914R;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178952085	178952085	A	T	Biomarker=H1047L;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178952085	178952085	A	G	Biomarker=H1047R;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178952084	178952084	C	T	Biomarker=H1047Y;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178928067	178928093	CCTCATGGATTAGAAGATTTGCTGAAC	-	Biomarker=H450_P458del;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916944	178916944	A	G	Biomarker=K111E;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916946	178916946	G	C	Biomarker=K111N;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916944	178916946	AAG	-	Biomarker=K111del;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178936076	178936084	CTCTCTGAA	CAAAGG	Biomarker=L540_E542delinsQR;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178952074	178952074	G	C	Biomarker=M1043I;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178952072	178952072	A	C	Biomarker=M1043L;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178952072	178952072	A	G	Biomarker=M1043V;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178952077	178952077	T	G	Biomarker=N1044K;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178952148	178952148	-	G	Biomarker=N1068Kfs*5;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178921552	178921552	A	T	Biomarker=N345I;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178921553	178921553	T	G	Biomarker=N345K;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178921552	178921552	A	C	Biomarker=N345T;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916924	178916924	C	T	Biomarker=P104L;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178922328	178922328	C	G	Biomarker=P366R;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178928060	178928086	GCCAGTACCTCATGGATTAGAAGATTT	-	Biomarker=P447_L455del;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178928067	178928067	C	A	Biomarker=P449T;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178928067	178928087	CCTCATGGATTAGAAGATTTG	-	Biomarker=P449_L455del|P449_L455delPHGLEDL;Evidence_level=1|3A|1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant|Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer|Breast_Cancer|Breast_Cancer
chr3	178928226	178928226	C	T	Biomarker=P471L;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178928274	178928274	C	A	Biomarker=P487Q;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178936074	178936074	C	G	Biomarker=P539R;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178936094	178936094	C	G	Biomarker=Q546E;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178936094	178936094	C	A	Biomarker=Q546K;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178936095	178936095	A	T	Biomarker=Q546L;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178936095	178936095	A	C	Biomarker=Q546P;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178936095	178936095	A	G	Biomarker=Q546R;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916936	178916936	G	A	Biomarker=R108H;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916936	178916936	G	T	Biomarker=R108L;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916725	178916725	C	T	Biomarker=R38C;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916726	178916726	G	A	Biomarker=R38H;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916876	178916876	G	A	Biomarker=R88Q;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916891	178916891	G	C	Biomarker=R93P;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916891	178916891	G	A	Biomarker=R93Q;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916890	178916890	C	T	Biomarker=R93W;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178937498	178937498	C	G	Biomarker=S629C;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178952018	178952018	A	G	Biomarker=T1025A;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178952019	178952019	C	A	Biomarker=T1025N;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178952019	178952019	C	G	Biomarker=T1025S;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178916926	178916937	GTAGGCAACCGT	-	Biomarker=V105_R108delVGNR;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178921549	178921549	T	C	Biomarker=V344A;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178921549	178921549	T	G	Biomarker=V344G;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178921548	178921548	G	A	Biomarker=V344M;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr3	178952006	178952006	T	C	Biomarker=Y1021H;Evidence_level=1|3A;Drug=Alpelisib+Fulvestrant|Buparlisib/Buparlisib+Fulvestrant/Copanlisib/GDC_0077/Serabelisib/Taselisib/Taselisib+Fulvestrant;Tumor_type=Breast_Cancer|Breast_Cancer
chr10	89692878	89692878	C	A	Biomarker=A121E;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692877	89692877	G	C	Biomarker=A121P;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692893	89692893	C	A	Biomarker=A126D;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692893	89692893	C	G	Biomarker=A126G;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692892	89692892	G	T	Biomarker=A126S;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692893	89692893	C	T	Biomarker=A126V;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89653803	89653803	C	A	Biomarker=A34D;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89653817	89653817	G	C	Biomarker=A39P;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692830	89692830	G	T	Biomarker=C105F;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692886	89692887	TG	AA	Biomarker=C124N;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692886	89692886	T	C	Biomarker=C124R;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692886	89692886	T	A	Biomarker=C124S;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692922	89692922	T	C	Biomarker=C136R;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692923	89692923	G	A	Biomarker=C136Y;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89690805	89690805	G	A	Biomarker=C71Y;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692835	89692835	G	T	Biomarker=D107Y;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89693001	89693001	A	G	Biomarker=D162G;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89693000	89693000	G	C	Biomarker=D162H;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89624296	89624296	G	A	Biomarker=D24N;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89624296	89624296	G	T	Biomarker=D24Y;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89717730	89717730	A	G	Biomarker=D252G;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89720825	89720825	G	A	Biomarker=D326N;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89720841	89720841	A	G	Biomarker=D331G;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692791	89692791	A	C	Biomarker=D92A;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692792	89692792	C	G	Biomarker=D92E;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692791	89692791	A	G	Biomarker=D92G;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692790	89692790	G	C	Biomarker=D92H;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692790	89692790	G	A	Biomarker=D92N;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692791	89692791	A	T	Biomarker=D92V;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692986	89692986	A	G	Biomarker=E157G;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692976	89692976	T	C	Biomarker=F154L;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89624287	89624288	TT	GC	Biomarker=F21A;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89717697	89717697	T	C	Biomarker=F241S;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89720870	89720870	T	G	Biomarker=F341V;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89725056	89725056	T	C	Biomarker=F347L;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692896	89692896	G	A	Biomarker=G127E;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692895	89692897	GGA	AAC	Biomarker=G127N;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692902	89692902	G	C	Biomarker=G129A;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692902	89692903	GA	AC	Biomarker=G129D;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692902	89692902	G	A	Biomarker=G129E;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692901	89692901	G	A	Biomarker=G129R;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89711876	89711876	G	A	Biomarker=G165E;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89711875	89711875	G	A	Biomarker=G165R;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89711876	89711876	G	T	Biomarker=G165V;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89624285	89624285	G	A	Biomarker=G20E;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89717726	89717726	G	T	Biomarker=G251C;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89653808	89653808	G	A	Biomarker=G36R;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89653833	89653833	G	A	Biomarker=G44D;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692869	89692869	A	C	Biomarker=H118P;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692883	89692883	C	G	Biomarker=H123D;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692885	89692885	C	A	Biomarker=H123Q;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692883	89692883	C	T	Biomarker=H123Y;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89685286	89685286	C	G	Biomarker=H61D;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89685287	89685287	A	G	Biomarker=H61R;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692793	89692793	C	G	Biomarker=H93D;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692795	89692795	T	A	Biomarker=H93Q;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692794	89692794	A	G	Biomarker=H93R;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692793	89692793	C	T	Biomarker=H93Y;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692880	89692880	A	C	Biomarker=I122L;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692881	89692881	T	G	Biomarker=I122S;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89711884	89711884	A	T	Biomarker=I168F;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89653796	89653798	ATT	-	Biomarker=I32del|I33del;Evidence_level=4|4;Drug=AZD8186/GSK2636771|AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors|All_Solid_Tumors
chr10	89692889	89692889	A	G	Biomarker=K125E;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692889	89692890	AA	CT	Biomarker=K125L;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692890	89692891	AA	TG	Biomarker=K125M;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692900	89692900	G	C	Biomarker=K128N;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692898	89692898	A	C	Biomarker=K128Q;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692899	89692899	A	G	Biomarker=K128R;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692899	89692899	A	C	Biomarker=K128T;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89720714	89720714	A	G	Biomarker=K289E;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89720875	89720875	G	C	Biomarker=K342N;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89685290	89685290	A	G	Biomarker=K62R;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692839	89692839	T	C	Biomarker=L108P;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692851	89692851	T	C	Biomarker=L112P;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692851	89692851	T	G	Biomarker=L112R;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89711924	89711924	T	C	Biomarker=L181P;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89624295	89624295	A	T	Biomarker=L23F;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89720808	89720808	T	C	Biomarker=L320S;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89720822	89720822	C	T	Biomarker=L325F;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89725051	89725051	T	A	Biomarker=L345Q;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89653827	89653827	T	G	Biomarker=L42R;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692916	89692916	A	C	Biomarker=M134L;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89711973	89711975	GAT	-	Biomarker=M199del;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89653806	89653806	T	G	Biomarker=M35R;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89720676	89720676	A	G	Biomarker=N276S;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89653846	89653846	C	G	Biomarker=N48K;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692797	89692797	A	T	Biomarker=N94I;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89711888	89711888	C	A	Biomarker=P169H;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89653815	89653815	C	T	Biomarker=P38L;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692800	89692800	C	T	Biomarker=P95L;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692799	89692799	C	T	Biomarker=P95S;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692803	89692803	C	A	Biomarker=P96Q;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692904	89692904	C	T	Biomarker=R130*;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692904	89692905	CG	GC	Biomarker=R130A;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692904	89692904	C	G	Biomarker=R130G;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692904	89692905	CG	AA	Biomarker=R130K;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692905	89692905	G	T	Biomarker=R130L;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692905	89692905	G	A	Biomarker=R130Q;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692991	89692991	A	G	Biomarker=R159G;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89624270	89624270	G	A	Biomarker=R15K;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89624271	89624271	A	C	Biomarker=R15S;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692997	89692997	A	G	Biomarker=R161G;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89711899	89711899	C	T	Biomarker=R173C;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89711900	89711900	G	A	Biomarker=R173H;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89711900	89711900	G	C	Biomarker=R173P;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89720852	89720852	C	T	Biomarker=R335*;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89720853	89720853	G	T	Biomarker=R335L;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89624255	89624255	G	A	Biomarker=S10N;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89711891	89711891	G	A	Biomarker=S170N;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89711892	89711892	T	G	Biomarker=S170R;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89717655	89717655	C	T	Biomarker=S227F;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692907	89692907	A	G	Biomarker=T131A;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692908	89692908	C	T	Biomarker=T131I;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692907	89692908	AC	CT	Biomarker=T131L;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692995	89692995	C	T	Biomarker=T160I;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89711881	89711881	A	G	Biomarker=T167A;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89720678	89720678	A	G	Biomarker=T277A;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89720804	89720804	A	G	Biomarker=T319A;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89720803	89720805	TAC	-	Biomarker=T319del;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89725219	89725219	C	T	Biomarker=T401I;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692913	89692913	G	A	Biomarker=V133I;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89717625	89717625	T	A	Biomarker=V217D;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89725045	89725045	T	A	Biomarker=V343E;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89725044	89725044	G	C	Biomarker=V343L;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89692980	89692980	A	G	Biomarker=Y155C;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89624273	89624273	A	G	Biomarker=Y16C;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89711902	89711902	T	A	Biomarker=Y174N;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89653782	89653782	A	C	Biomarker=Y27S;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89685299	89685299	A	G	Biomarker=Y65C;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89685307	89685307	T	G	Biomarker=Y68D;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr10	89685307	89685307	T	C	Biomarker=Y68H;Evidence_level=4;Drug=AZD8186/GSK2636771;Tumor_type=All_Solid_Tumors
chr3	12627260	12627260	C	T	Biomarker=D486N;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr3	12627284	12627284	C	T	Biomarker=E478K;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr3	12641216	12641216	C	G	Biomarker=G361A;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr3	12632325	12632325	T	C	Biomarker=I448V;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr3	12653451	12653451	T	G	Biomarker=K106N;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr3	12626123	12626123	G	C	Biomarker=L613V;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr3	12629100	12629100	C	G	Biomarker=M469I;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr3	12645687	12645687	G	A	Biomarker=P261L;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr3	12645688	12645688	G	A	Biomarker=P261S;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr3	12645688	12645688	G	T	Biomarker=P261T;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr3	12633229	12633229	T	A	Biomarker=R391W;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr3	12645699	12645699	G	A	Biomarker=S257L;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr3	12645700	12645700	A	G	Biomarker=S257P;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr3	12645699	12645699	G	C	Biomarker=S257W;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr3	12645694	12645694	A	C	Biomarker=S259A;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr3	12645693	12645693	G	A	Biomarker=S259F;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr3	12645694	12645694	A	G	Biomarker=S259P;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr3	12632388	12632388	T	C	Biomarker=S427G;Evidence_level=3A;Drug=Cobimetinib;Tumor_type=Histiocytosis
chr10	43615568	43615569	GC	TT	Biomarker=A883F;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43615568	43615568	G	A	Biomarker=A883T;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43617419	43617419	C	T	Biomarker=A919V;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43609070	43609070	G	A	Biomarker=C609Y;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43609076	43609076	G	A	Biomarker=C611Y;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43609096	43609096	T	C	Biomarker=C618R;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43609102	43609102	T	C	Biomarker=C620R;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43609936	43609936	T	C	Biomarker=C630R;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43609948	43609948	T	C	Biomarker=C634R;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43609948	43609948	T	A	Biomarker=C634S;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43609950	43609950	C	G	Biomarker=C634W;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43609949	43609949	G	A	Biomarker=C634Y;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43609939	43609939	G	T	Biomarker=D631Y;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43609941	43609946	CGAGCT	-	Biomarker=D631_L633delinsE;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43607555	43607555	G	A	Biomarker=E511K;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43609942	43609947	GAGCTG	-	Biomarker=E632_L633del;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43613840	43613840	G	C	Biomarker=E768D;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43615142	43615142	C	G	Biomarker=I852M;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43609051	43609051	A	C	Biomarker=K603Q;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43613906	43613906	G	T	Biomarker=L790F;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43615129	43615129	T	C	Biomarker=M848T;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43617416	43617416	T	C	Biomarker=M918T;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43617415	43617415	A	G	Biomarker=M918V;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43615083	43615083	C	T	Biomarker=R833C;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43615577	43615577	C	T	Biomarker=R886W;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43615592	43615592	T	G	Biomarker=S891A;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43615632	43615632	C	T	Biomarker=S904F;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43601969	43601969	C	T	Biomarker=T338I;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43609990	43609990	G	A	Biomarker=V648I;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43614996	43614996	G	C	Biomarker=V804L;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43614996	43614996	G	A	Biomarker=V804M;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43613908	43613908	A	T	Biomarker=Y791F;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr10	43615003	43615003	A	G	Biomarker=Y806C;Evidence_level=3A;Drug=BLU_667/LOXO_292;Tumor_type=Medullary_Thyroid_Cancer
chr2	198267491	198267491	C	G	Biomarker=E622D;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia|Acute_Myeloid_Leukemia
chr2	198267493	198267493	C	G	Biomarker=E622Q;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia|Acute_Myeloid_Leukemia
chr2	198266611	198266611	C	T	Biomarker=G742D;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia|Acute_Myeloid_Leukemia
chr2	198267373	198267373	G	C	Biomarker=H662D;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia|Acute_Myeloid_Leukemia
chr2	198267371	198267371	G	T	Biomarker=H662Q;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia|Acute_Myeloid_Leukemia
chr2	198267372	198267372	T	C	Biomarker=H662R;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia|Acute_Myeloid_Leukemia
chr2	198267360	198267360	T	A	Biomarker=K666M;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia|Acute_Myeloid_Leukemia
chr2	198267359	198267359	C	G	Biomarker=K666N;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia|Acute_Myeloid_Leukemia
chr2	198267360	198267360	T	C	Biomarker=K666R;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia|Acute_Myeloid_Leukemia
chr2	198267360	198267360	T	G	Biomarker=K666T;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia|Acute_Myeloid_Leukemia
chr2	198266834	198266834	T	C	Biomarker=K700E;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia|Acute_Myeloid_Leukemia
chr2	198266833	198266833	T	C	Biomarker=K700R;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia|Acute_Myeloid_Leukemia
chr2	198267484	198267484	G	A	Biomarker=R625C;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia|Acute_Myeloid_Leukemia
chr2	198267483	198267484	CG	GA	Biomarker=R625D;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia|Acute_Myeloid_Leukemia
chr2	198267484	198267484	G	C	Biomarker=R625G;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia|Acute_Myeloid_Leukemia
chr2	198267483	198267483	C	T	Biomarker=R625H;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia|Acute_Myeloid_Leukemia
chr2	198267483	198267483	C	A	Biomarker=R625L;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia|Acute_Myeloid_Leukemia
chr2	198265007	198265007	C	T	Biomarker=R957Q;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia|Acute_Myeloid_Leukemia
chr17	74732959	74732959	G	T	Biomarker=P95H;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Acute_Myeloid_Leukemia|Myelodysplastic_Syndromes|Chronic_Myelomonocytic_Leukemia
chr9	135798770	135798770	A	C	Biomarker=F158C;Evidence_level=1|2A;Drug=Everolimus|Everolimus;Tumor_type=CNS_Cancer|Renal_Cell_Carcinoma
chr9	135797222	135797223	TT	GC	Biomarker=F216A;Evidence_level=1|2A;Drug=Everolimus|Everolimus;Tumor_type=CNS_Cancer|Renal_Cell_Carcinoma
chr9	135801023	135801023	T	C	Biomarker=H105R;Evidence_level=1|2A;Drug=Everolimus|Everolimus;Tumor_type=CNS_Cancer|Renal_Cell_Carcinoma
chr9	135797253	135797253	G	C	Biomarker=H206D;Evidence_level=1|2A;Drug=Everolimus|Everolimus;Tumor_type=CNS_Cancer|Renal_Cell_Carcinoma
chr9	135802595	135802595	T	C	Biomarker=H68R;Evidence_level=1|2A;Drug=Everolimus|Everolimus;Tumor_type=CNS_Cancer|Renal_Cell_Carcinoma
chr9	135800987	135800987	A	G	Biomarker=L117P;Evidence_level=1|2A;Drug=Everolimus|Everolimus;Tumor_type=CNS_Cancer|Renal_Cell_Carcinoma
chr9	135797330	135797330	A	G	Biomarker=L180P;Evidence_level=1|2A;Drug=Everolimus|Everolimus;Tumor_type=CNS_Cancer|Renal_Cell_Carcinoma
chr9	135797297	135797297	A	T	Biomarker=L191H;Evidence_level=1|2A;Drug=Everolimus|Everolimus;Tumor_type=CNS_Cancer|Renal_Cell_Carcinoma
chr9	135796816	135796816	A	C	Biomarker=M224R;Evidence_level=1|2A;Drug=Everolimus|Everolimus;Tumor_type=CNS_Cancer|Renal_Cell_Carcinoma
chr9	135797274	135797276	AGT	-	Biomarker=N198_F199delinsI;Evidence_level=1|2A;Drug=Everolimus|Everolimus;Tumor_type=CNS_Cancer|Renal_Cell_Carcinoma
chr9	135804155	135804157	TCT	CAA	Biomarker=S35Q;Evidence_level=1|2A;Drug=Everolimus|Everolimus;Tumor_type=CNS_Cancer|Renal_Cell_Carcinoma
chr9	135798859	135798861	GAC	-	Biomarker=V128del;Evidence_level=1|2A;Drug=Everolimus|Everolimus;Tumor_type=CNS_Cancer|Renal_Cell_Carcinoma
chr16	2110677	2110677	G	C	Biomarker=A328P;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2121512	2121512	C	A	Biomarker=A614D;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2126094	2126094	G	C	Biomarker=A889P;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2121925	2121925	G	A	Biomarker=C696Y;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2135314	2135316	AGA	-	Biomarker=E1552del;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2100486	2100486	A	G	Biomarker=E75G;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2121515	2121515	T	C	Biomarker=F615S;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2136231	2136231	G	A	Biomarker=G1567D;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2136318	2136318	G	T	Biomarker=G1596V;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2136742	2136742	A	G	Biomarker=H1620R;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2120529	2120529	C	T	Biomarker=H597Y;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2112521	2112521	C	G	Biomarker=I427M;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2104397	2104397	T	G	Biomarker=L146R;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2136282	2136282	T	G	Biomarker=L1584R;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2111981	2111981	T	G	Biomarker=L410R;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2112583	2112583	T	C	Biomarker=L448P;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2114307	2114307	T	C	Biomarker=L493P;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2114306	2114306	C	G	Biomarker=L493V;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2124220	2124220	T	G	Biomarker=L792R;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2124322	2124322	T	C	Biomarker=L826P;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2124334	2124334	T	G	Biomarker=L830R;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2124376	2124376	T	G	Biomarker=L844R;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2137898	2137898	C	T	Biomarker=P1675L;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2138106	2138106	C	T	Biomarker=P1709L;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2134966	2134966	A	C	Biomarker=Q1503P;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2135323	2135323	G	T	Biomarker=Q1554H;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2130366	2130366	C	T	Biomarker=R1200W;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2112995	2112995	C	T	Biomarker=R462C;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2114343	2114343	G	A	Biomarker=R505Q;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2120572	2120572	G	A	Biomarker=R611Q;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2120571	2120571	C	T	Biomarker=R611W;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2126142	2126142	C	G	Biomarker=R905G;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2126143	2126143	G	A	Biomarker=R905Q;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2126142	2126142	C	T	Biomarker=R905W;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2129172	2129172	T	C	Biomarker=S1036P;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2134716	2134716	G	A	Biomarker=S1498N;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2136841	2136841	C	T	Biomarker=S1653F;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2136840	2136840	T	C	Biomarker=S1653P;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2130376	2130376	C	A	Biomarker=T1203K;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2136751	2136751	C	T	Biomarker=T1623I;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2137892	2137892	T	A	Biomarker=V1673D;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2137891	2137891	G	T	Biomarker=V1673F;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2106717	2106719	GTT	-	Biomarker=V241del;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2108795	2108795	T	G	Biomarker=V299G;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2122258	2122258	T	A	Biomarker=V705E;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2122257	2122257	G	A	Biomarker=V705M;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2122935	2122935	T	A	Biomarker=V769E;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2136359	2136359	T	G	Biomarker=W1610G;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2136242	2136242	T	A	Biomarker=Y1571N;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr16	2120533	2120533	A	G	Biomarker=Y598C;Evidence_level=2A|1;Drug=Everolimus|Everolimus;Tumor_type=Renal_Cell_Carcinoma|CNS_Cancer
chr21	44524486	44524486	A	G	Biomarker=I24T;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Chronic_Myelomonocytic_Leukemia|Myelodysplastic_Syndromes|Acute_Myeloid_Leukemia
chr21	44514777	44514777	T	G	Biomarker=Q157P;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Chronic_Myelomonocytic_Leukemia|Myelodysplastic_Syndromes|Acute_Myeloid_Leukemia
chr21	44514777	44514777	T	C	Biomarker=Q157R;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Chronic_Myelomonocytic_Leukemia|Myelodysplastic_Syndromes|Acute_Myeloid_Leukemia
chr21	44524456	44524456	G	A	Biomarker=S34F;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Chronic_Myelomonocytic_Leukemia|Myelodysplastic_Syndromes|Acute_Myeloid_Leukemia
chr21	44524456	44524456	G	T	Biomarker=S34Y;Evidence_level=4|4|4;Drug=H3B_8800|H3B_8800|H3B_8800;Tumor_type=Chronic_Myelomonocytic_Leukemia|Myelodysplastic_Syndromes|Acute_Myeloid_Leukemia
